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Abstract
Signal Transducers and Activators of Transcription (STAT) proteins were discovered
as targets for interferon activation. These proteins are dormant in the cytoplasm
until they are activated by one or more cytokines, that interact with their cognate
cell surface receptors. These extracellular signaling proteins can activate various
tyrosine kinases inside the cell that phosphorylate the STAT proteins. The activated
STAT proteins migrate to the nucleus and drive transcription. Since STAT activity is
modulated by several post-translational modifications and protein-protein interactions,
these transcription factors are capable of integrating inputs from multiple signaling net-
works. The carboxy-terminal region of the STAT proteins functions as a transcriptional
activation domain. Seven mammalian STATs have been discovered so far. Inspite of
the progress that has been made in identifying the interaction targets of the activation
domains and the recognition of the importance of particular residues for their function,
the structural basis for the ability of transactivation domains to stimulate transcription
is not understood well. The structural understanding of the transactivation domains is
barely developed, in contrast to the well known DNA-binding domains. This thesis work
involved the biochemical and structural characterization of the interaction between the
transactivation domain of STAT6 and its co-factor, the Nuclear Receptor Co-activator
-1(NCoA-1). The amino acid sequences in both STAT6 and NCoA-1 involved in this
interaction had been identified previously.
The sequence spanning amino acids 794-814 in the STAT6 C- terminal region was
identified to be essential in mediating the interaction with NCoA-1 and comprised of
a LXXLL motif. In the case of NCoA-1, the region between the amino acids 213-462
had been identified to be involved in the interaction. The complex was reconstituted in
vitro. Biochemical characterization of this complex using techniques like gel filtration,
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limited proteolysis, mass spectroscopy and protein sequencing suggested that the
residues 257-385 of the NCoA-1 is the minimal domain required for the interaction with
the STAT6 and that the ratio of the binding partners in the complex was 1:1. Secondary
structure prediction showed that the region C- terminal to residue 366 in the NCoA-1
was unstructured. Two shorter constructs of NCoA-1, one spanning residues 257-385
and other comprising of residues 257-370 were cloned for further experiments.
Titration calorimetry showed that the dissociation constant of the binding was in the
order of 10−7M. The crystal structure of the complex between the NCoA-1(257−385) and
STAT6(794−814) peptide revealed that the NCoA-1(257−385) fragment in complex with
STAT6(794−814) peptide forms a canonical Per-Arnt-Sim (PAS) domain. The free forms of
both the NCoA-1 constructs failed to crystallize, therefore NMR was used for the study
of these constructs. Isotope labeled NCoA-1(257−385) and NCoA-1(257−370) fragments
were used for multidimensional NMR experiments. Backbone resonance assignment
proved that the residues C- terminal to amino acid 366 were unstructured. Further
structural analysis using Residual Dipolar Couplings (RDCs) was not successful, as
the couplings obtained were not suitable for such studies. The reason was that the
alignment of the protein in liquid crystalline medium which is a pre-requisite for the
measurement of dipolar couplings was not optimal.
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Chapter 1
Introduction
Man is distinguished from mouse in not having very different proteins or different
numbers of them, but rather in having a common set of proteins, which are temporally
and spatially separated in the developing organism[1, 2]. This separation is achieved
by transcribing or repressing specific genes, degrading or stabilizing particular proteins,
splicing RNA transcripts in one way or the other etc.,[3, 4, 5]. The distinction in the
phenotype among various kinds of cells in higher eukaryotes are largely due to the
differences in expression of genes encoding different proteins[6, 7]. Therefore, in spite
of the prodigious numbers of coding sequences in their genomes and the apparent
enormity of the task of genetic control, only a limited set of genes is used to generate
diversity in functions and complexity in living organisms[8]. Most eukaryotic cells,
except the haploid sex cells, contain the same set of genes. Yet, each specialised cell type
expresses only a small fraction of the genome[9]. Selective gene expression allows cells
to be metabolically strict, synthesizing only those gene products that are of immediate
use under the prevailing environmental conditions. In multicellular organisms selective
gene expression allows cells to fulfill specialized roles[10]. This process is described as
cellular regulation, in simplest terms and its study calls for expertise from different
branches of science. A simple mechanism called regulated recruitment forms the
basis of many of the regulatory decisions taken by the cells, whether they constitute
unicellular or multicellular organisms. The same regulatory processes not only generate
the intricacy involved in the development of a complex organism from a single fertilized
egg or the evolution of different forms of life, but also enable the cells to respond to
their surroundings[11]. Proliferation of the cells and differentiation processes, that
1
2 Chapter1. Introduction
underlie development are controlled by programs of regulated gene expression within
the embryo. Higher life forms must continue to respond to various endogenous and
exogenous stimuli to maintain the functioning of the adult organism, in the course of
post-natal development. These stimuli induce specific adaptive responses that involve
quantitative and qualitative changes in gene expression.
The ability of the cells to respond to essential signals in their environment con-
stitutes one of the most fundamental features of life. These signals may have a
variety of forms from simple organic molecules to large peptides, temperature, light
or pressure. They may trigger an immediate change in the metabolism of the cell,
change the electrical charge distribution across the plasma membrane or change the
gene expression by initiating transcription inside the cell’s nucleus. The increased
knowledge of cellular signaling offers the opportunity to develop novel substances that
target specific pathway molecules. Eukaryotic gene expression is regulated by multiple
control mechanisms acting on at least several different levels - (i) the formation and
maintenance of inactive and active chromatin, (ii) disruption of the nucleosome to
form a productive transcription unit, (iii) processing of transcription (iv) transport of
the mRNA to the cytoplasm, (v) translation of the mRNA, (vi) mRNA stability (vii)
protein activation and stability[6, 3]. As eukaryotic DNA is highly folded, transcription
is regulated to some extent by the uncoiling of appropriate chromosomal regions.
However, these structural changes in the active region of the genome do not answer
the question how the DNA sequences are selected for activation. The answer is to
be found in the phenomenon of transcriptional control. Most intracellular signaling
proteins function as modular switches[12]. In eukaryotes, many of these proteins seem
to have a component-based architecture[13] and some of them have catalytic functions
whereas others mediate protein-protein or protein-lipid interactions[14].
Prokaryotic RNA polymerase can initiate transcription on its own, but eukaryotic
polymerases (RNA polymerases I, II and III) require formation of an assembly of addi-
tional transcription factors called the general transcription factors before the initiation
of transcription[15]. This assembly provides a platform for transcriptional regulation,
as many eukaryotic regulatory proteins are thought to work by aiding or inhibiting this
process. Some of them activate while others repress transcription. These proteins bind
to regulatory sequences arranged in modules in the DNA sequence, and the proteins
themselves are called trans-acting proteins whereas the DNA sequences that participate
in this interaction are called cis-acting elements[16]. The transcription machinery
3consists of the core RNA polymerase and these transcription factors, 40 of them have
been discovered so far, They were found to be assembled stepwise, during trials to
assemble this machinery in vitro[17].
Most of the transcription factors have several modules in common, [18], they are :
1. DNA binding domain 2.Activation domains 3.Dimerization domain 4.Ligand
binding domains
Some regulatory transcription factors do not have direct contacts with the basal
transcription machinery1, but instead bind to co-activators that contact the basal
apparatus[19, 20]. General transcription factors, essential for the transcription of all
genes, are required for initiating RNA synthesis at all promoters[20]. They assemble
with the RNA polymerase at the core promoter[21], a DNA region consisting of a
short initiator sequence at the transcriptional start point[15], and 2˜5 nucleotides
upstream, a TATA box,2[22, 23] to form a complex surrounding the site of initiation
of transcription. The interaction of the general factors with RNA polymerase at the
core promoter initiates a low basal transcription rate. In addition to their own core
promoter, most genes have short DNA sequences upstream or downstream to which
other transcription factors can bind, dramatically improving the efficiency of the
transcription of the core promoter[24]. These sequences called response elements,
allow transcription to be tuned up or down, in response to various types of signals.
Those which increase the rate of transcription are called enhancers and those that
decrease it are called silencers[25, 26]. Placement of the same response element
adjacent to genes residing at different chromosomal loci, allows a group of genes to
be coordinately transcribed and their expression is regulated by the same regulatory
protein. Transcription factors that selectively bind to one of the response elements, or
to other DNA control elements located outside the core promoter, are called regulatory
transcription factors. They increase or decrease the rate of transcription initiation, by
interacting with the components of the basal transcription apparatus. This stimulation
of transcription by a transcription factor binding to the DNA and activating adjacent
proteins is known as transactivation[27, 28]. There are two types of transcription
factors.
1The RNA polymerase and its associated proteins
2A eukaryotic DNA element upstream of the transcription start site.
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1. Upstream factors are DNA binding proteins that recognize specific short se-
quences located upstream of the initiation start point[18]. The activity of these factors
is not regulated[29]. They are ubiquitous[26], and act upon any promoter that contains
the appropriate binding region on DNA, increasing the efficiency of initiation.
2. Inducible factors function in the same general way, but have a regulatory role. They
are synthesized and activated at specific times or in specific tissues.
Both the upstream and inducible factors function by interacting with certain general
factors in the basal transcription apparatus. A gene is expressed at a maximum
level only when the set of transcription factors present includes all the regulatory
transcription factors that bind to the gene’s positive control elements[3, 30, 31].
Transcription factors contain at least two major domains : A DNA binding domain,
responsible for tethering the transcription factor to the DNA helix and an activation
domain (responsible for interaction with the general transcription apparatus to promote
transcription)[32]. The activity of the transcription factors may be controlled by
changing their DNA binding affinity in response to extracellular signals.
An ever increasing body of information suggests that proteins involved in the reg-
ulation of cellular events such gene expression, signal transduction, the cell cycle,
protein trafficking, targeted proteolysis and cytoskeletal organization are constructed in
a modular fashion from a combination of interacting and catalyzing domains[33, 12].
Interaction domains direct signaling polypeptides into specific multi-protein complexes,
and link cell surface receptors to intracellular biochemical pathways that control cellu-
lar responses to external signals. The pathways and networks that connect receptors
to their ultimate targets frequently involve a series of protein-protein interactions.
As a consequence of these interactions signaling proteins recruited and confined to
appropriate subcellular locations. These interactions determine the specificity with
which enzymes interact with their targets, e.g. association of protein kinases and their
substrates[34]. In an era of whole genome sequencing, hundreds of proteins essential
for cellular regulation have been identified[35]. However, this list reveals neither the
exact function of these proteins, nor their assembling into the molecular machinery
and functional networks that control the cellular behavior[11]. The regulation of the
cellular processes requires the interaction of protein domains, with one another and
with phospholipids, small molecules or nucleic acids. Evolution of cellular signaling
pathways is likely to have been facilitated by the modular nature of these domains and
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1.0.1 Modular Interaction Domains
Interaction domains usually consist of 35-150 amino acids and can fold independently
with their N- and C- termini abutted to each other in space. They can be expressed
in isolation from their host proteins while retaining their intrinsic ability to bind their
physiological partners. They can be incorporated into a larger protein such that their
ligand-binding surface is exposed through which they recognize exposed surfaces on
their partner molecules. A protein interaction typically recognizes a core determinant,
where additional contacts and an element of selectivity are provided by flanking or non-
contiguous residues[37]. The affinity of a single domain for a polypeptide motif alone is
sufficient for a particular interaction in cells, in some cases. Selectivity in signaling can
also be attributed to tertiary interactions, the structural organization of the interacting
proteins and subcellular localization, domain competition, and multidomain interac-
tions, in vivo. Consensus amino acid sequences allow signaling domains to be identified,
which permit the prediction of binding properties and biological functions of a protein,
based on the domain composition[38]. In the human genome, several interaction
domains are found in hundreds of copies, and they are used repeatedly to regulate
distinct aspects of cellular organization[35]. For example, about 115 SH2 domains
and 253 SH3 domains are encoded by the human genome[39, 40, 41]. Some domains
have specific functions whereas others can bind motifs from a bigger set of proteins
and display a wider range of biological activity. SH3 domains, for example, regulate
processes such as signal transduction, protein and vesicular trafficking, cytoskeletal
organization, cell polarization and organelle biogenesis[39, 41]. Versatility in binding
properties is a characteristic of interacting domains. Several distinct ligands can be
engaged by an individual domain, either simultaneously or at successive stages of
signaling[42, 43, 44, 45]. Different members of the same domain type can bind to
various motifs. Another way of building interaction surfaces is through the joining
of repeated copies of a small peptide motif, forming a much larger structure with
multifaceted binding properties. Many modular domains undergo homo- or hetero
typic domain-domain interactions. Such domains frequently identify proteins in a
common signaling process and then direct their coassembly into functional oligomeric
complexes[46]. There is no absolute distinction between the domains that bind peptide
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motifs and those that interact with other folded domains[47].
1.0.2 Modular Signaling Systems
Interaction domains couple various cell surface receptors with their targets, and medi-
ate the formation of signaling complexes in the cytoplasm and the nucleus[48]. They
also play a role in regulating targeted proteolysis, endocytosis, vesicle and protein
trafficking, cell polarity, cytoskeletal organization and gene expression. Strikingly
common strategies are used by these different regulatory systems to assemble func-
tional complexes, to compartmentalize molecular components and to direct enzymes
to their targets[11]. In principle, by analyzing the in vitro binding specificities of
interaction domains and by directly analyzing protein complexes by techniques such
as mass spectrometry and yeast two hybrid analysis, it is possible to assemble a circuit
for cellular protein interactions. The repeated use of signaling domains might have led
to the evolution of new cellular functions, because the domains may be joined in new
combinations to create new connections and pathways inside the cell. The fusion of
separate domains can also create a new composite protein entity with more complex
properties than either of the domain alone. Thus interaction domains provide a way
to increase the connectivity of existing proteins, and impart new functions to these
proteins. Recruitment of positive or negative regulators, that exhibit feed-forward or
feedback control is an example for protein-protein interactions that can influence the
signaling kinetics. In addition to this, if a protein-protein interaction is dependent on
secondary events like phosphorylation at multiple sites, this may create a switch like
response, as the activity of the relevant kinase rises above a certain threshold.
1.0.3 Transactivation Domains
The domains of the regulatory proteins that bind to other proteins are called trans-
activation domains, and are functional modules which enable sequence specific DNA
binding to stimulate transcription. Activation domains are classified according to the
preponderance of amino acid residues such as glutamine, proline and those bearing
acidic side chains. Among these classes, the third class, which are called acidic
activators, is the most extensively studied[49].
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A consistent theme has emerged from the studies of the functional domains that
bind to DNA sites distant from the RNA polymerase II initiation sites. These distant
binding sites require one or more proteins that integrate the activating potential of
the distant binding factor with the RNA polymerase II and other general transcription
factors. These integrating factors are called co-activators, mediators, or TATA box
binding protein-associated factors. When contacted by a distant DNA binding factor,
the integrating proteins enhance the probability that RNA polymerase II will begin
transcription at a particular site.
1.1 Topic for the thesis
The topic chosen for the thesis is the structural analysis of the interaction between a
particular transactivation domain, that of the STAT6 and its coactivator protein, the
NCoA-1.
1.2 STAT (Signal Transducers and Activators of Tran-
scription) Proteins
The STAT (Signal Transducers and Activators of Transcription) are named after their
dual role as signal transducers and activators of transcription[50]. The STAT proteins
were discovered as targets for interferon activation[51]. These proteins are dormant
in the cytoplasm until they are activated by one or more cytokines, that interact with
their cognate cell surface receptors. These extracellular signaling proteins can activate
various tyrosine kinases inside the cell that phosphorylate the STAT proteins[52]. The
activated STAT proteins migrate to the nucleus and drive transcription. These proteins
need to cross the cell membrane to get linked with the cytokine-responsive genes. Since
STAT activity is modulated by several post-translational modifications and protein-
protein interactions, these transcription factors are capable of integrating inputs from
multiple signaling networks.
The carboxy-terminal region of the STAT proteins functions as a transcriptional
activation domain. STATs 1,3,4,5a and 5b have relatively short carboxy terminal
regions of about 40 to 50 amino acids whereas STATs 2 and 6 have extended C-
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STAT protein Phenotype of null mice
STAT1 Impaired responses to interferons; increased
susceptiblity to tumors; impaired growth control
STAT2 Impaired responses to interferons
STAT3 Embryonic lethality; impaired response to pathogens
STAT4 Impaired TH1 differentiation owing to loss of Il-12 responsiveness
STAT5A Impaired mammary gland development owing to loss of prolactin
responsiveness
STAT5B Impaired growth owing to loss of growth hormone responsiveness
STAT6 Impaired TH1 differentiation owing to loss of Il-4 responsiveness
Table 1.1: Role of STAT proteins as revealed by gene targeting in mice (adapted from Darnell
et al., 2002)
terminal domains[53]. STAT6 has been shown to be the most common transducer
of the interleukin (IL-4) receptor α chain and mediates IL-4- and IL-13- initiated
responses[54]. IL-4 and IL-13 are considered to be the crucial cytokines involved in the
development of type II allergic diseases because IL-4 can promote immunoglobulin class
switching to the IgE isotype in B cells[55] and IL-4 and IL-13 mediate the induction of
Th2 differentiation[56]. Mice which are deficient in STAT6 genes are defective in IL-4
and IL-13 induced Th2 cell differentiation and IL-4 induced class switching of B cells
to IgE and IgG1 isotypes[57]. In addition, STAT6 knock-out mice are protected from
antigen-induced respiratory tract hyper-responsiveness and mucus production, and also
from IL-13 induced respiratory tract hyper-responsiveness[51].
Seven mammalian STATs have been identified[53]which range in size from 750-850
amino acids. Chromosomal mapping of the mouse and human genes showed that, in
both species, the STAT genes are localized in clusters, STAT1 and STAT4 in one group,
STAT2 and STAT6 in the second group, STAT3 and STAT5a, STAT5b in the third set[58].
The STAT family of genes is evolutionarily conserved, and a STAT gene has been found
in the lower eukaryote Dictyostelium discoidium[59]. The finding that STAT genes are
not present in yeast suggests that the emergence of this protein family was an early step
in the evolution of multicellular organisms. A STAT gene has also been identified in
Drosophila[60]. The similarity of Dictyostelium and Drosophila STATs to STAT5 suggests
that it is the ancestral gene. Table 1.1 shows the effect of the deficiency of different
STATs in mouse models.
1.2. STAT proteins 9
1.2.1 Transcriptional coregulators of STATs
The activity of STAT 3 and 5 has been shown to be upregulated by their interaction with
transcription factors/co-regulators like Cyclic AMP Response Element Binding Protein
(CREB) binding protein (CBP), Centrosomal P4.1 Associated Protein (CPAP), c-jun, Si-
lencing Mediator for Retinoid Thyroid Hormone Receptors (SMRT), the glucocorticoid
receptor and histone deacetylases[61]. STAT1 synergically acts with Sp1[62], while
STAT6 interacts with CBP at a composite Interleukin-4 (IL-4) response element site[63].
The association of CBP with the STAT family proteins is thought to be rate limiting
to the process of transactivation. CBP has been shown to interact with STAT1 and
STAT2 and STAT6. CBP binds to serine- phosphorylated transcription factors and RNA
polymerase. Some STATs have been known to be associated physically and functionally
with coactivator proteins. It is possible that more than one co-operating factor can
associate with the same STAT, providing a mechanism by which that same STAT can be
involved in the activation of different cell types or activation sites, depending on which
co-operating factors are expressed.
1.2.2 Functional architecture of the STAT proteins
All the STATs share the same functional organization as shown in the Figure 1.1,
with six conserved domains, the N-terminal domain, the linker domain, the coiled
coiled domain, the DNA binding domain, the Src-homology 2 (SH2) domain and the
C- terminal transcriptional activation domain[63].
The N- terminal domain comprising of approximately 130 amino acids (Figure 1.1),
is responsible for co-operative binding to multiple DNA sites[64]. It is an indepen-
dently folded and stable moiety which can be cleaved from the full-length molecule
by limited proteolysis. The crystal structure of the N-terminus of STAT4 reveals a
dimer[65]. Studies suggest that this N- terminal dimerization promotes co-operativity
of binding[64, 66, 65]. The N-terminal STAT domain is involved in the interaction with
the transcriptional coactivator, CREB 3 binding protein (CBP)/p300[67], the Protein
Inhibitor of Activated STAT (PIAS) family, receptor domains, and it regulates nuclear
translocation[68]. A flexible polypeptide chain links the N- terminal domain to the
coiled-coil domain which consists of four α helices (approximately amino acids 135-
3cyclic AMP response element binding protein
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Figure 1.1: Organization of the functional domains in STAT family proteins
The SH2 domains mediate receptor binding and dimerization. The DNA-binding domain
is located in the center of the molecule. The amino-terminal domain confers dimer-dimer
interaction involved in the co-operative DNA binding. The transcriptional activation domains
of the STAT proteins in located at the carboxy-terminal end.
315). The crystal structures of STAT1 and STAT3 reveal that this domain protrudes
about 80 A˚ A laterally from the core structure[69, 70]. This domain forms a large,
predominantly hydrophilic surface that is available for specific interactions with other
helical proteins. Studies have also implicated the coiled-coil domain in receptor
binding, tyrosine phosphorylation and nuclear export[71, 72]. Figure 1.2a shows
the structure of a STAT3β homodimer. Figure 1.2b shows the domain boundaries in
the monomer. The structure lacks the both the extreme N- and C- terminal regions,
namely the cooperative DNA binding and the transactivation domains. A bundle of four
antiparallel helices constitutes the N-terminal domain, which is followed by an eight
stranded β-barrel. The β-barrel domain is linked to the SH2 domain by a small helical
domain, formed by two helix-loop-helix modules. Apart from the STAT3 β homodimer,
other STAT molecules that have been structurally characterized are STAT1 and STAT4.
The DNA binding domain (approximately amino acids 320 - 480) is a β, barrel with
an immunoglobulin fold and lies C-terminal to the coiled-coil domain[70]. The number
of direct contact sites between amino acid residues and DNA is modest, accounting for
a dissociation constant in the nanomolar range. The DNA binding domain is located
at the center of the STATs[73]. All the STATs have similar DNA binding specificities
in vitro[73]. A palindromic sequence TTCnnnGAA (where n is any amino acid) is the
optimal binding site for STATs 1,3,4 and 5[74]. STAT6 binds to the same palindromic
sequence but with a spacing of four nucleotides.
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Figure 1.2: (a) Crystal structure of STAT3β homo dimer in complex with DNA (from Becker et
al, [69]). (b) Diagrammatic representation of the domain arrangement in STAT3 β monomer.
The linker domain connects the DNA-binding domain with the SH2/dimerization
domain. Mutational studies have also implicated the linker domain of STAT1 in
transcriptional regulation[75].
SH2 domains play an important role in signaling through their capacity to bind to
specific phosphotyrosine motifs. It is the most highly conserved STAT domain. The SH2
domain of the Dictyostelium STAT appears to represent one of the earliest identified
SH2 domains [59]. Although the sequence of the STAT SH2 domain (residues 580-
680) is quite divergent from other SH2 domains, its structure is well conserved. It
consists of an anti-parallel β-sheet flanked by two α-helices, which form a pocket. An
absolutely conserved arginine, which mediates the interaction with phosphate, lies at
the base of this pocket (Arg-602 for STAT1, Arg-609 for STAT3). The ability of this SH2
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domain to recognize specific phosphotyrosine motifs plays an essential role in three
STAT signaling events: (1) recruitment to the cytokine receptor through recognition of
specific receptor phosphotyrosine motifs. (2) association with the activating JAK [76].
(3) STAT homo- or heterodimerization [77]. DNA binding capacity can be regulated
by structural changes in the SH2 domain as it binds phosphotyrosine[70]. As seen in
the crystal structures, STAT dimerization depends on the interaction between the SH2
domain of one STAT monomer and the tyrosine phosphorylated tail segment of the
other monomer. Residues most involved in defining the specificity of the interaction
between the SH2 domain and tyrosine motif are located at positions +1, +3 and
+5, +6, +7 C-terminal to the phosphotyrosine [70]. Closely positioned amino acids
of the SH2 domain (e.g. Ala-641, Val-642) appear to participate in this interaction.
All STATs except STAT2 have been shown to form stable homodimers in vitro and in
vivo. Additionally, many STATs, including STAT2, can heterodimerize with other STATs
through this reciprocal SH2-phosphotyrosine interaction [78].
Consistent with its ability to regulate unique transcriptional responses, the carboxy-
terminal domain is poorly conserved among the STATs. The first evidence that the
carboxy-terminus encodes transcriptional activation domain (TAD) came from a com-
parative analysis of the full-length STAT1 and an alternatively spliced isoform STAT1β,
which lacks the last 38 carboxy-terminal amino acids [79]. Well characterized C-
terminally truncated isoforms have also been identified for STAT3, STAT4 and STAT5
[80]. They appear to function as dominant-negative regulators.
Although a detailed understanding of how the STAT carboxy-terminus regulates
transcription remains to be determined, important progress has been made. It has
been determined that the transcriptional activity of several STATs can be modulated
through serine phosphorylation [81]. Serine phosphorylation appears to enhance the
transcription of some, but not all target genes. The highly conserved amino-terminal
region of the STAT family is also involved in the dimer-dimer interactions leading to
co-operative DNA binding[66].
1.2.3 JAK-STAT Pathway
Figure 1.3 shows a model of Jak-STAT pathway. Signaling through the JAK/STAT
pathway is initiated when a cytokine binds to its corresponding receptor. This binding
leads to conformational changes in the cytoplasmic part of the receptor, which lead
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Figure 1.3: A schematic representation of the Jak-STAT pathway
to the recruitment of receptor associated members of the receptor associated Janus
kinase (JAK) family of kinases. The JAKs in turn mediate the phosphorylation of specific
tyrosine residues in the cytoplasmic tail of the cytokine receptor. These phosphorylated
tyrosines then serve as docking sites for specific STATs. Once docked to the receptor
the STAT molecule also becomes phosphorylated by JAKs, on a single tyrosine residue
around amino acid 700 in the STAT molecule. These activated STATs then dissociate
from the receptors and dimerize. Thereafter, they translocate to the nucleus and bind
to DNA regions that belong to Gamma Activated Site (GAS) family of gene enhancers.
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Figure 1.4: A schematic representation of the Jak-STAT6 pathway
JAK-STAT Pathway-with respect to STAT6
Figure 1.4 represents the JAK-STAT pathway. With STAT6 as the STAT component, IL-4
stimulation results in activation of Janus kinase 1 and 3, which in turn phosphorylate
tyrosine residues in the cytoplasmic domain of the IL-4 receptor α. Thereafter, the
STAT6 is recruited to the cytosolic domain of the receptor, which interacts with the
phosphotyrosine residues via its SH2 domain. Subsequently, STAT6 gets phosphorylated
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at Tyr694 by the Janus kinase, dimerizes and translocates to the nucleus where it
modulates transcription through binding to STAT6 response elements. STAT6-binding
elements were identified in the I² promoter, the CD23 promoter, and the IL-4 promoter.
It has been shown by Arimura et al[82]., that STAT6 acts both as a positive and negative
regulator of the gene expression induced by IL-4. Upstream of the phosphorylated
tyrosine residue is the SH2 domain which is involved in the recognition of the activated
receptors and in the mediation of the STAT dimerization. The DNA binding domain
(DBD) of STAT6 lies between amino acid residues 268-448[73].
At least two different coactivators, p300/CBP and the Nuclear receptor Coactivator
-1 (NCoA-1) are required for the transcriptional induction by IL-4 and they interact
with the STAT6 transactivation domain (TAD)[83, 84]. p300 and CBP are functionally
related multifunctional coactivators that participate in transcriptional activation by
multiple transcription factors[20]. They possess an intrinsic histone deacetyl trans-
ferase (HAT) activity. Distinct domains for binding to several transcription factors,
other coactivators and components of the basal transcription machinery have been
characterized. p300/CBP was shown to increase IL-4 induced transcription of STAT6
reporter genes[83]. The region of CBP that interacts with STAT6 was distinct from
interaction domain of CBP with other STAT family members. However it also contains
the interaction site with the coactivators of the NCoA family[85, 86]. Nuclear Receptor
Coactivators (NCoAs), also called the p160- or SRC (steroid receptor coactivators) were
originally identified as nuclear receptor binding proteins, which enhance transcriptional
activation by these ligand induced transcription factors.
1.2.4 Identification of a transactivation domain in STAT6
The carboxy-terminal region of both human and mouse STAT6 are proline rich, a
common feature of some classes of transactivation domains[87]. To determine whether
STAT6 contains a region capable of activating transcription, the modular property of
transcription factors was exploited to generate fusion proteins, in which parts of the
STAT6 molecule were fused to the DNA binding region of a heterologous protein,
Gal4. The level of expression of these Gal4-STAT6 fusion proteins is not affected by
the addition of IL-4 to these cultures. These experiments demonstrated that STAT6
contains a modular transcription activation domain that does not need IL-4 for its
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activation function. Similar experiments with different lengths of the carboxy-terminal
of the STAT6 fused with Gal4 protein were used to map the exact location of this
trans-activation domain. The carboxy-terminal region of the STAT6 is required for IL-4
inducible transcription[87].
1.2.5 Nuclear Receptor Coactivators (NCoAs)
Coactivators are defined as proteins that can interact with DNA-bound nuclear re-
ceptors and enhance their transcriptional activation function[88]. Numerous nuclear
receptor coactivators have been identified[89], particularly the steroid receptor coacti-
vator (SRC) family has been extensively studied, in recent years[90]. The steroid and
thyroid nuclear receptor superfamily is a large class of ligand-dependent transcription
factors involved in the regulation of genes that play crucial roles in a wide range
of biological processes like reproduction, development and homeostasis[91]. The
steroid receptor coactivator 1 (SRC-1) was the first nuclear receptor coactivator to be
cloned[88].
The members of the SRC-1 family of coactivators also share a common
structure[92]. Figure 1.5 shows the domain arrangement in SRC family proteins.
The N- terminal bHLH (Helix-Loop-Helix)-Per-Arnt-Sim(PAS)4region is the most
conserved region in all the members of this family. The bHLH and the PAS motifs
play a role in protein-protein interactions and dimerization[93]. The bHLH-PAS
4Per-Arnt-Sim domain : All the three domains had similar folds and were the first domains of this
structural family to be identified
SRC
bHLH
PAS A PAS B
HAT
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CBP/p300
Figure 1.5: Domain arrangement in SRC family proteins
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Figure 1.6: Location of LXXLL motifs in NCoA-1 and CBP
domain is followed by a central receptor interaction domain (RID) and a C-terminal
transcriptional activation domain (AD). Analysis of the sequence of the RID revealed
a conserved LXXLL motif, where L is leucine and X is any amino acid, that is termed
the ’NR’5box[94]. This sequence has been identified in a number of proteins. Three
such motifs were found in the RID of SRC coactivators. These motifs are required for
mediating interactions between coactivators and liganded nuclear receptors. Figure
1.6 shows the location of LXXLL motifs in NCoA and CBP molecules. There are several
types of recognition interfaces between the nuclear receptors and their coactivators.
But a large number of these interactions are mediated by the highly conserved NR
box[94]. Crystallographic and protein structure prediction analyses have shown
that these motifs form amphipathic helices, with the leucine residues forming a
hydrophobic surface on one side of the helix. Interestingly, different nuclear receptors
prefer different NR boxes of the RID for interaction with coactivators, indicating the
existence of a receptor-specific code. However, mutation of a single motif does not
completely abolish coactivator interaction with nuclear receptors, since multiple NR
5NR-Nuclear Receptor
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boxes contribute to the overall, high affinity binding to the receptor. The LXXLL motif is
essential to mediate the binding of these coactivators to the ligand bound NRs, amino
acids flanking the core motif are important for the recognition of NRs[95]. NCoA
coactivators are also involved in transcriptional activation by several transcriptional
activators, like AP-1, p53, Serum Response Factor (SRF), Nuclear Factor κB (NFκB)
and STAT1[96]. Only one member of NCoA family proteins, the NCoA-1 interacts with
STAT6[97].
1.2.6 Transcriptional activation by STAT6 requires direct interac-
tion with NCoA-1
Transfection assays using a luciferase reporter construct with multimerized STAT6
response elements were carried out in IL-4 responsive liver HepG2 cells[84]. Vectors
containing the coding sequences for NCoA-1, NCoA-2 and NCoA-3 were cotransfected.
After transfection, the cells were treated with IL-4 and untreated cells were used
as control. In comparison to the cells untreated with IL-4, induction with IL-4 led
to a 6-fold increase in the reporter gene expression. The reporter gene expression
was enhanced up to 20 times, when NCoA-1 was present, whereas cotransfection
with NCoA-2 and NCoA-3 did not have any effect. In a further study, two Gal4
fusion constructs with STAT6 amino acids (677-791) and STAT6 amino acids 792-
847 representing the N- and C- terminal regions of the STAT6 transactivation domains
respectively, were used to assay gene expression. The results showed that NCoA-1
effected a stronger coactivation on the C-terminal part of the STAT6 TAD than the N-
terminal part. Litterst et al. [97], found that the N-terminal part of the STAT6 TAD
recruited CBP, but the far C-terminal part of the TAD directly contacted the NCoA-1.
They suggested a model (see Figure 1.7) where NCoA-1 binds to the C-terminal
part of the STAT6-TAD and recruits CBP which interacts directly with the N-terminal
part of the STAT6 TAD. Multiple interactions of CBP, NCoA-1, and STAT6 would stabilize
binding to the promoter.
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Figure 1.7: A schematic illustration showing simultaneous interaction between CBP,
NCoA-1 and STAT transactivation domain
1.2.7 Preliminary studies of the NCoA-1 domain that interacts
with the STAT6 transactivation domain
Based on GST-pull down assays Litterst et al[84]identified that the region comprising
amino acids 213-462 that contains the predicted PAS-B domain and serine/threonine
rich region in the NCoA-1 was identified to be necessary for its interaction with
the STAT6 TAD. The existing model of transcriptional activation proposes that coac-
tivators function as bridging factors, to recruit additional cofactors, and the basal
transcriptional machinery to the DNA bound transcriptional factors. Some of them
also function chromatin remodeling enzymes. NCoA-1 through its bHLH-PAS domain
coactivates the transactivation of STAT6 and through its C- terminus also binds to the
CBP/p300. The bound CBP could possibly stabilize the NCoA-1/STAT6 interaction
because it binds to STAT6 TAD at a region close to the NCoA-1 binding site. CBP
possesses histone acetylase activity required for chromatin remodeling. This concerted
interaction between CBP/p300, NCoA-1 and STAT6 TAD leads to the transcription of
the IL-4 responsive germ line (GL) ² gene. It is not yet known, if the expression of other
STAT6 activated genes like GL γ1, CD23, and the Major Histocompatibility Complex
(MHC) are dependent on this mechanism.
1.2.8 An LXXLL motif in the Transactivation domain of STAT6 me-
diates recruitment of NCoA-1/SRC-1
Litterst et al[97] identified that a 56-amino acid sequence, in the STAT6-TAD from
amino acids 792-847 mediates the recruitment of NCoA-1. They showed that a peptide
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containing the LXXLL signature motif of STAT6 from amino acids 794-814, and the
antibodies for this peptide were strong inhibitors of the interaction of the STAT6 domain
with NCoA-1 in vitro. They also showed that the mutations (L802A and L805A) of
the STAT6-LXXLL motif, abolish the NCoA-1 binding, both in vitro and in vivo. It was
found that the STAT6 LXXLL motif has sequence homology to the known coactivator
motifs, but does not interfere with NR/coactivator interactions, suggesting that this
motif might represent a specific target for STAT6 inhibition. Further, the LXXLL motif
of the STAT6 is required for transactivation, but not involved in DNA-binding.
The NCoA coactivators were identified as nuclear receptor-binding proteins, which
enhance transcriptional activation by ligand-induced transcription factors. Three ho-
mologous factors, termed NCoA-1, also called SRC-1 [98, 99]; NCoA-2, also called
TIF2 or Glutamate Receptor Interacting Protein 1 (GRIP1)[100]; and NCoA-3, also
called p/CIP, Activin Receptor Protein (ACTR), or Amplified in Breast Cancer 1 (AIB1)
[101, 88, 102], have been identified by several laboratories. Subsequently a number
of transcription factors have been shown to recruit these coactivators. It has been
proposed that distinct classes of transcription factors selectively use specific coactivators
and histone acetyltransferase activities for their function [20, 103]. In accordance
with this model, a specific role of NCoA-1 was observed, but not of NCoA-2 or
NCoA-3, for STAT6-mediated transactivation[84]. Only NCoA-1 acts as a coactivator
of STAT6. STAT6 directly contacts NCoA-1 via a small carboxyl-terminal part of its
transactivation domain. Overexpression of the STAT6-interacting domain of NCoA-
1 inhibits transactivation by STAT6 in a transdominant manner, demonstrating the
importance of NCoA-1 for STAT6 transactivation. An LXXLL motif (where L is leucine
and X is any amino acid) with a predicted alpha -helical structure was indentified
in the shortest NCoA-1 interacting fragment of the STAT6-TAD. The alpha -helical
LXXLL motif was originally found in a variety of coactivators, e.g. NCoA/p160/SRC
members, p300/CBP, RIP-140. It is described as a signature motif, which mediates the
recruitment of these proteins by the nuclear hormone receptors [94]. Specific LXXLL
motifs of NCoAs mediate the ligand-dependent interaction with nuclear receptors, as
well as interaction with p300/CBP. STAT6 recruits NCoA-1 via an LXXLL motif in its
transactivation domain. A peptide containing the LXXLL motif of STAT6, as well as
antibodies raised against this peptide, are potent inhibitors of the interaction with
NCoA-1 in vitro. Mutagenesis of the STAT6-LXXLL motif abolishes the binding of NCoA-
1 in vitro and in vivo. A STAT6 variant, in which the LXXLL motif is mutated, is less
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active in induction of a STAT6-dependent reporter gene. The LXXLL mutant of STAT6
shows impaired induction of eotaxin-3 expression, indicating that recruitment of NCoA-
1 by the STAT6-LXXLL motif is essential for full transactivation of this endogenous
target gene. The LXXLL motif of STAT6 shows no sequence homology to the known
coactivator motifs. NCoA-1 does not only use its own LXXLL motifs to contact DNA-
bound factors and coactivators, but can also be recruited itself by an LXXLL motif of
DNA-bound transcription factors, such as STAT6[97]. Based on the above studies,
a peptide containing amino acids 794-814 of the STAT6 transactivation domain and
a construct containing the amino acids 257-420 of the NCoA-1 were selected for
structural analysis.
1.3 Justification of the scientific question
Transcriptional activation is mediated by large protein complexes assembled on target
gene promoter regions. These complexes contain activators and coactivators of tran-
scription as well as elements of basal transcription machinery. The specificity, timing,
and degree of transcriptional activation depend not only on the proteins forming the
complex, but also on the way they interact with each other. Coactivators are part
of chromatin remodeling complexes, and serve as bridges to the basal transcription
machinery [104]. Inspite of the progress that has been made in identifying the
interaction targets of the acidic activation domains and the recognition of the im-
portance of particular residues for their function, the structural basis for the ability
of transactivation domains to stimulate transcription is not understood well. The
structural understanding of the transactivation domains is barely developed, in contrast
to the well known DNA-binding domains. The reason is partly because transactivation
domains share little sequence similarity. They have a poor intrinsic propensity to
form secondary structure, although they apparently need to make specific interactions
with several different target factors[53]. The structural analysis of the transactivation
domains is highly hampered by the highly flexible conformation of such domains in the
unbound state. Most transactivation domains adopt a regular structure only in complex
with a coactivator. This functional conformation is brought about by an induced
fit. This corroborates the idea that the minimal requirement for partner recognition
is defined by very short stretches of amino acids, which become structured only
22 Chapter1. Introduction
when bound to target proteins. While the LXXLL and similar motifs form structurally
homologous amphipathic helices, their target proteins share no structural similarity.
Structural analysis, in particular solving the three dimensional structure of the complex
between a transactivation domain and its cofactor would make a very important
contribution to this very active research field.
The aim of this thesis work is to structurally characterize the complex between the
transactivation domain of STAT6 and the transactivation domain interacting region of
the NCoA-1 as well as the free form of the NCoA-1, using NMR (Nuclear Magnetic
Resonance), crystallography and biochemical methods. Thereby the implications of
this structure for the specificity of the STAT6 trans-activation domain and NCoA-1 and
in general the mechanism of a transactivation domain-cofactor interaction would be
better understood.
Chapter 2
Materials and Methods
2.1 Materials
Chemicals and reagents were purchased from Roth, Merck, and Sigma, unless specified
otherwise. 15N H4Cl, 13C - glucose were obtained from Spectral Isotopes. Enzymes and
buffers were from New England Biolabs (Beverly, MA). Plasmid purification kits were
from Qiagen (Hildesheim, Germany).
2.1.1 Buffers and Solutions
Table 2.1 gives the composition of the buffers and reagents used in this thesis work.
2.1.2 Media
Luria Bertani (LB) medium - for expressing unlabeled proteins (10 g/L tryptone, 5
g/L yeast extract, 10 g/L NaCl, pH 7.4)
Minimal medium - for 15N and 15N /13C labeled proteins:200 ml 5× M9 salts, 20
ml 20% glucose , 2 ml 1M MgSO4, 50µl, 2M CaCl2, 6 ml 1mg/ml Thiamin,adjusted to
1 litre with double distilled H2O.
OD2 rich medium (Silantes R©) for 15N and15N / 13C labeling of proteins. A certain
chemolithoautotrophic bacterial lysate supplied with M9 salts. The OD level gives an
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Experiment Buffer/Solution Components
His6 purification Lysis Buffer 20 mM Tris-HCl, 500
mM NaCl,
on Ni-NTA agarose 20 mM Imidazole, 0.5
mM PMSF, pH 7.9
Complete R©1 without
EDTA
Wash buffer 20 mM Tris-HCl, 500
mM NaCl
40 mM Imidazole, 0.5
mM PMSF, pH 7.9
Elution buffer A 20 mM Tris-HCl, 500
mM NaCl
100 mM Imidazole, 0.5
mM PMSF, pH 7.9
Elution buffer B 20 mM Tris-HCl, 500
mM NaCl
100 mM Imidazole, 0.5
mM PMSF, pH 7.9
TEV digestion TEV digestion buffer 50 mM Tris-HCl, 300
mM NaCl, pH 8.0
NMR NMR buffer 50 mM NaH2PO4, 150
mM NaCl,
1 mM DTT, pH 6.5
Crystal screening HEPES buffer 50 mM HEPES, 150 mM
NaCl,
1 mM DTT, pH 7.0
5 × M9 salts 33.9 g of Na2HPO4, 15
mg KH2PO4,
2.5 g NaCl, 5 gm NH4Cl,
in 1 litre of dd H2O
adjusted to pH 7.4 and
autoclaved.
Polyvinylidene fluoride
10× CAPS buffer 221.13 gms of CAPS in
900 ml of ddH2O
(PVDF) Blotting pH 11.0
Transfer Buffer 100 ml of 10× CAPS
buffer, 100 ml methanol,
800 ml dd H2O
Table 2.1: Table showing various buffers
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indication of the amount of enriched compounds present in the medium2. For example,
in the OD2 medium, uninduced bacteria of common strains like BL21DE3 can grow up
to an OD of 2.0 at 600 nm.
2× Yeast Tryptone (YT) medium : for transformation purpose (16g bacto-tryptone,
bacto-yeast extract 10g, NaCl 5g)
2.1.3 Bacterial strains
E. coli XL2Blue for cloning.
E. coli BL21DE3 for expression.
2.1.4 Expression vectors
Table 2.2: Expression vectors used for expression
Vector Antibiotic marker Affinity tag Protease
pET16b (NEB) Ampicillin N-His6 TEV
pTWIN1 Ampicillin Chitin binding domain Intein based splicing
2.1.5 Oligonucleotide primers
Primer Sequence Restriction Sites
NCoA-1(257−370) EP-7 : 5’-GCTAAGCTTCATATGACGGGTGTAGAATCCTTTATGACC - 3’ NdeI and Bam H1
EP-9neu : 5’-GCTCTCGAGGGATCCCTACCCACTGTGCTGCCTGTCG-3’
NCoA-1(257−385) EP-7 : 5’-GCTAAGCTTCATATGACGGGTGTAGAATCCTTTATGACC - 3’ NdeI and Bam H1
EP-14 : 5’-GGTCTCGAGGGATCCTTATCGGGGAATTGACATTCCAGAATTAG-3’
NCoA-1(257−420) EP-7: 5’-GCTAAGCTTCATATGACGGGTGTAGAATCCTTTATGACC - 3’ NdeI and Bam H1
EP-8 : 5’ -GCTCTCGAGGGATCCCTAGCGGTTTATTCTGGTGGATACC-3’
Table 2.3: Primers and restriction enzymes used for cloning NCoA-1 constructs
2data from Silantes media manual
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2.2 Biochemical Methods
2.2.1 Cloning of NCoA-1 fragments
Fragments containing 257-385, 257-370, 257-420 of the NCoA-1 PAS-B region were
cloned into a modified pET16B (Novagen) vector containing a Tobacco-Etch-Virus (TEV)
protease cleavage site. A full length NCoA-1 clone provided by Dr. Edith Pfitzner, Georg
Speyer Haus, University of Frankfurt. All NCoA-1 constructs were derived from the full
length clone using appropriate primers as shown in Table 2.3.
Polymerase Chain Reaction (PCR) was performed with the NCoA-1 full length
fragment in pET30C as the template. The primers used for different constructs are
listed in Table 2.3. After an initial incubation at 95 ◦C, 25 cycles were performed, with
each cycle consisting of an incubation for 3 seconds at 95 ◦C and annealing at 55 ◦C
for a minute followed by extension for 3 minutes at 68 ◦C. The amplified fragments
were digested with the appropriate restriction enzymes (refer Table 2.3) for 3 hours
at 37 ◦C. The pET16b vector was linearized using appropriate restriction enzymes
mentioned in Table 2.3 based on the domain to be cloned. The digested vectors were
treated calf intestinal phosphatase (Boehringer Mannheim) with to prevent self-ligation
in the following step. These fragments were ligated into the previously linearized
pET16b expression vector using T4 DNA ligase (MBI Fermentas) by incubation at 14 ◦C
overnight. All the restriction enzymes were purchased from MBI Fermentas.
2.2.2 Expression and Purification of NCoA-1
Transformation
About 1µl of a miniprep of the respective expression construct was added to 50µl
of calcium-competent BL21DE3 (Stratagene) cells. After an incubation on ice for 30
minutes, the cells were subjected to a heat shock of 42 ◦C for 30 seconds, and incubated
again in ice for 2 minutes. The cells were transferred to 1 ml of prewarmed YT medium,
and incubated at 37 ◦C for 1 hour after which they were pelleted down. About 850 µl
of the supernatant was discarded and the remaining medium was used to resuspend
the cells, and they were plated on LB agar plates with ampicillin as selection marker.
The plates were incubated overnight at 37 ◦C, and colonies developed on them. The
plates were stored at 4 ◦C.
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Expression of NCoA-1
A single colony was picked from a fresh plate, inoculated into 2 ml of LB medium with
ampicillin and incubated at 37 ◦C for 6 hours. When the culture turned slightly turbid,
10 µl of this culture was used to inoculate 50 ml of LB medium which was shaken
overnight in a baffled conical flask. The next day, the culture was diluted into 1 litre of
LB medium. The cells were grown up to an optical density (O.D.600nm) of 0.45 at 600
nm and then transferred to 28 ◦C, grown to an O.D.600nm of 0.75. At this point, the cells
were induced with 0.4 mM isopropyl β-thiogalactoside (IPTG), for 7 hours. Thereafter,
they were harvested by centrifuging at 6000 r.p.m. for 15 minutes at 4 ◦C, and stored
at -80 ◦C.
Purification of NCoA-1 fragments
The frozen cells were thawed in ice and resuspended in lysis buffer. This suspension
was kept in ice and sonicated 8 times for 20 seconds, with the maximum power at 80
%, each time. The sample was cooled for 4 minutes on ice between the sonication
steps. After sonication, this suspension was centrifuged using a Beckman centrifuge for
45 minutes, 20,000 r.p.m., at 4 ◦C. The supernatant was incubated for 60 minutes at
4◦ C with pre-equilibrated Ni-NTA resin (Qiagen), on a tumbling shaker. The pellet was
stored for further analysis. After incubation, the supernatant and resin mixture was
taken in a 10 ml polypropylene column (Pierce) and the flow through was collected.
The resin was washed with 20 ml of lysis buffer and 20 ml wash buffer. The NCoA-1
fragment was eluted along with the histidine tag within 10 × 1.5 ml fractions, first with
elution buffer A and followed by elution buffer B (see Table 2.1). Fifteen microlitres of
the flow through, the first wash, the second wash, and each of the 20 elution fractions
and a scoop of the resin were taken for analysis with a 15% SDS-PAGE gel.
The fractions containing the protein were pooled together and dialyzed against
TEV digestion buffer, overnight at 4 ◦C, using Spectrapor R©, 3500 MW cutoff dialysis
membrane. Proteolysis was performed using a TEV concentration of 1.0 mg/100 mg
of the protein. The extent of digestion was periodically checked using 15% SDS-
Polyacrylamide (PAGE) gels. After the complete digestion, the protein was dialyzed
overnight against a buffer containing 20 mM Tris-HCl, pH 7.9, 500 mM NaCl and 25
mM imidazole at 4 ◦C. The dialyzed NCoA-1 was incubated with 1 ml of Ni-NTA resin
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and then loaded on a 10 ml column. The flow through which contained the NCoA-1
alone was collected, whereas the histidine tag remained bound to the column. The
resin was washed with 6 × 1 ml of the same dialysis buffer. The flowthrough and
the wash fractions containing the digested protein were pooled together and dialyzed
against an appropriate buffer for further studies.
2.2.3 Media switch
The commercially available isotope labeled medium and minimal medium enriched
with isotopes are relatively expensive, especially when the expression level from these
media is low. In these cases, the amount of labeled medium required can be reduced
by growing the cells in LB medium up to the point of induction with IPTG, and after
induction the cells are washed with M9 salts and transferred to a lower volume of
labelling medium. The protein of interest is expressed only after induction by IPTG,
where the cells are introduced into a medium in which the nitrogen and carbon are
isotope-labeled. During translation, most of the protein would have 15N and 13C
isotopes incorporated into their amino acids. This media switch protocol was used
in the case of producing isotope labeled NCoA-1(257−385) and NCoA-1(257−370) fragments,
where the cells were grown at 37 ◦C up to an O.D.600nm = 0.75 at 37 ◦C and washed
with M9 salts twice before being resuspended in a labeled medium and induced with
IPTG. The ratio of shrinkage from unlabeled medium to labeled medium was usually 3
: 1.
2.2.4 Protocol for the expression and purification of the
NCoA-1(257−385) fragment
The general protocol mentioned in the section 2.2.2. was also employed in the expres-
sion and purification of the NCoA-1(257−385) and NCoA-1(257−370) fragments. But a few
changes had to be made to the protocol when expressing NCoA-1(257−385) fragment and
while purifying the NCoA-1(257−370) fragment. The yield of NCoA-1(257−385) fragment
was comparatively lower than that of the NCoA-1(257−420) and NCoA-1(257−370) using the
same expression strategy. Therefore, a different protocol was employed in the case of
the expression of NCoA-1(257−385). Cells were grown for 4 hours in 3 ml of LB preculture,
and transferred to 20 ml LB medium with ampicillin. The next morning the cells were
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transferred to 1 litre of LB medium and grown until they reached an O. D. 600 = 0.75,
centrifuged at 4000 r.p.m for 4 minutes and washed twice with 1 × M9 salts. After
the wash, the cells were resuspended in 300 ml of doubly labeled Silantes medium and
induced with 0.025 mM IPTG, doubling the IPTG added, every hour for the next 3
hours, at 37◦C. After 3 hours, the cells were transferred to a temperature of 18◦ C and
grown for about 20 hours. NCoA-1(257−385) was purified using the same protocol that
was used for other constructs of NCoA-1.
2.2.5 The problem of impurity in the purification of NCoA-1257−420
fragment
The NCoA-1(257−370) purified through the Ni-NTA process had a strong absorption at
260 nm, suggesting the possibility of DNA bound to the protein. This absorption was
removed by increasing NaCl from 500 mM to 1 M and adding DNAse 1 to the lysis
buffer which was used to resuspend the thawed cell pellet before sonication.
2.2.6 Electrophoresis
Polyacrylamide gel electrophoresis with Sodium Dodecyl Sulphate (SDS) is a powerful
tool to separate polypeptides in complex biological solutions[105]. Gel electrophoresis
was done using SDS buffer at 25 mA, using a Biorad gel electrophoresis appartus.
The protein was stained with Coomassie and the gel was destained using 10% acetic
acid[106].
2.2.7 Gel Filtration
The NCoA-1(257−385) protein fragment was dialyzed against 50 mM HEPES buffer, pH
7.0, with 150 mM NaCl. STAT6(794−814) peptide was added in 5 times molar excess and
incubated at room temperature, for about 1 hour and the sample was concentrated upto
0.9 mM using a Vivaspin R© (Sartorius) 10 kDa molecular weight cut-off concentrator
at a speed of 6000×g. The concentrated sample was passed through a pre-equilibrated
Superdex HR 75 R© (Amersham) column. The fractions corresponding to the UV
absorption peak at 280 nm were checked for eluted protein.
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2.2.8 Limited Proteolysis
Many studies have demonstrated the utility of limited proteolysis as a very useful
tool to probe conformational states of proteins[107, 108]. A protein substrate can be
proteolysed only if the polypeptide chain in question can bind and adapt to the specific
stereochemistry of the protease’s active site[109]. Since the active sites of proteases do
not fit a stretch of a globular protein at least 8-10 amino acids in length, adaptation of
a globular protein substrate to the active site of the polypeptide is not possible[110].
In the case of locally disordered or unfolded domains, there is enhanced segmental
mobility and conformational flexibility, which makes these regions suitable for attack
by the protease enzyme[111, 112]. To analyse the minimal fragment of NCoA-1 that
interacts with the STAT6(794−814) fragment, NCoA-1(257−420) and the complex of NCoA-
1(257−420) with STAT6794−814 were subjected to a limited proteolysis experiment using
trypsin as the protease. Different ratios of the protease to its substrate were used
at varying lengths time. The reaction was stopped by quick freezing the mixture in
liquid nitrogen. Samples were also taken for analysis with a 15% SDS polyacrylamide
gel. The resuting bands of protein were blotted on a Polyvinylidine Fluoride (PVDF)
membrane. The protein transferred to the membrane was N-terminally sequenced by
Edman degradation.
2.2.9 Polyvinylidine Fluoride (PVDF) Blotting
The advantage of PVDF blotting is that it removes all free SDS and buffer salts and the
blotted protein is suitable for direct NH2-terminal sequencing[113]. The membrane
was prepared by immersing it in 100 % methanol for 1 minute and three times in 1 ×
transfer buffer for 15 minutes, changing the buffer each time. The gel was incubated
in the transfer buffer for 5 minutes. The membrane and the gel were assembled in
a Biorad blot transfer apparatus, along with strips of Whatman filter paper soaked in
transfer buffer. Transfer of the protein from the gel to protein was done by applying
a voltage difference of 60 V across the gel to the membrane, for 35 minutes. After
the transfer, the membrane was removed, rinsed with water twice, and washed with
methanol. The transferred protein was stained by Coomassie and destained by washing
the membrane three times in 50 % methanol.
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2.2.10 Mass Spectrometry
Fractions from the corresponding samples used for PVDF blotting were taken for
mass spectroscopic analysis. The measurements were performed in the laboratory
of Dr. Henning Urlaub, MPI for Biophysical Chemistry, using a Bruker (Karlsruhe,
Germany) Matrix Assisted Laser Desorption and Ionization(MALDI) [114, 115, 116]
mass spectrometer.
2.2.11 Circular Dichroism(CD)
CD spectra of different NCoA-1 fragments were measured at a concentration of 50 µM,
with the same buffer conditions used for NMR measurements (see NMR Buffer Table
2.1). The sample for the CD spectroscopy consisted of 50 µM of the NCoA-1 protein
taken in a quartz cuvette of 0.2 cm pathlength. The spectra were measured using
a JASCO CD spectrometer at 20 ◦C. Phosphate buffer, containing 50 mM Na2HPO4,
and 150 mM NaCl, 1 mM DTT and pH 6.5 was used throughout the measurements.
STAT6(794−814) peptide was also dissolved in the above buffer such that the concentra-
tion was 50 µM and a CD spectrum was measured. A complex between the NCoA-
1(257−370) fragment and STAT6(794−814) peptide was constituted in the above buffer, and
the final concentration of the complex that was used for CD measurements was 50 µM.
The spectra were analyzed using SpectralView software supplied by JASCO Corporation,
Osaka, Japan. All the measurements were performed using the same set of parameters.
2.2.12 Fluorescence spectroscopy
Thiol reactive dyes
A 10 mM stock solution of Texas Red R© dye (Molecular Probes) was prepared in the
same buffer as the protein. The solution was protected from light as much as possible
by wrapping the container in aluminium foil. In order to attach fluorescent dyes for
anisotropy studies, STAT6 peptides with N- terminal and C- terminal cysteines were
synthesized using solid phase peptide synthesis[117] and purified using High Pressure
Liquid Chromatography(HPLC). Texas Red was added in 20 times molar excess and
incubated at 4 ◦C overnight. The sample was checked for dye labeled peptide using
Electron Spray Ionization (ESI)-Mass spectrometer(Waters).
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Synthesis of a fluorescent labeled probe
Fluorescein is a popular probe for biophysical studies, because of it biocompatibility.
Carboxyfluorescein, especially has remained the molecule of choice for the preparation
of hydrolytically stable fluorescent peptides, and conjugated proteins. Fluorescein-
labeled peptide derivatives have been employed as fluorescent markers in many bio-
physical and cell biological applications. STAT6 peptides (amino acids 801-814) were
synthesized separately with N- and C- terminal cysteines with a carboxyfluorescein
dye attached to the cysteins. These peptides were used as probes for detecting
conformational changes in the NCoA-1(257−370) fragment upon titration. The fluoresence
emission was measured during the process of stepwise titration of the peptides into
NCoA-1(257−370) sample of 0.01 mM concentration inside a quartz cuvette fitted with a
magnetic stirrer. The starting concentration of the peptide was 0.001 mM and it was
increased in 0.001 mM steps.
2.2.13 Isothermal Titration Calorimetry
Experimental Setup
The samples were degassed for 5-10 minutes with care to avoid evaporation. It was
ensured that the samples were devoid of any precipitation, since it would influence
the heat of the reaction. The NCoA-1(257−370) sample solution was carefully filled into
the reaction cell of the ITC unit of a Microcal MCS-2 calorimeter, by using a Hamilton
syringe, without introducing any air bubbles, as the presence of even tiny air bubbles
might lead to serious artifacts in the signal. Prior to the experiment, the cell and its
contents were equilibrated with its surroundings to have the same temperature, so that
neither heat is lost nor gained.
Design of an ITC experiment
From the crystal structure of the complex between NCoA-1(257−370) and STAT6794−814
fragment, it was evident that only one peptide molecule binds to a single NCoA-1
molecule. In the case where there is only one binding site on a macromolecule M
to which a ligand X binds, then,
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according to the law of mass action, the binding constant,KA, is given by,
KA =
[boundsites]
[unboundsites][X]
(2.1)
and,
4G0 = −RT lnKA = RT lnKD = ∆H − T∆ S (2.2)
where,
R = gas constant (8.314 J K−1 mol−1)
T= absolute temperature (in K, degrees Kelvin)
KA=Association constant in units of concentration−1 (expressed as Moles−1 )
KD=Dissociation constant in units of concentration(expressed as Moles )
∆ H = Enthalpy (kcal/Mole) ∆ S = Entropy (kcal/Mole)
In biochemistry, dissociation constants are used, as the units are easier to follow.
∆H =
∆Q
∆X
(2.3)
∆ H is expressed in kcal/mol. where,
∆Q - total heat released under each titration point
∆X- number of moles of the ligand
The power released/second (µJ/sec.) was plotted and a characteristic pattern of
peaks was obtained. The area under each peak was integrated to obtain the total heat
released at a titration point (∆ Q). This value is divided by the diluted concentration
of the ligand at each titration point and the values were plotted. In the case of NCoA-
1(257 − 385)/STAT6(794-814) interaction, a molar ratio of binding at equilibrium was
expected as indicated from the biochemical studies. Therefore, ∆ H was calculated for
this ratio of the protein/peptide.
By using a non-linear squares fit of calorimetric titration data KD is determined in a
single experiment.
Titration
The number of steps of the titration depends on the following factors:[118]
(i) sensitivity of the equipment to detect signals, (ii) energy released or absorbed during
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the reaction, (iii) time taken by the process to reach the equilibrium, (iv) additional
processes like conformational changes, (v) concentrations of the interacting partners.
In order to get accurate results, the number of titration steps were increased as
much as possible.
A series of samples of NCoA-1(257−370) were made, such that there were 25
nanomoles, 35 nanomoles, 45 nanomoles, 60 nanomoles, 75 nanomoles in the
reaction cell (volume of the reaction cell = 1.33 ml). The samples were filled in the
cell such that it was flowing over the brim, to avoid air bubbles in the cell of the
calorimeter.
The STAT6 peptide was taken in exactly the same buffer as NCoA-1(257−370). The pH
was the same in both NCoA-1(257−370) and STAT6 peptide solutions to avoid artifacts.
Since the STAT6 peptide solution could be concentrated much farther than the NCoA-
1(257−370), >> 5mM, it was used as a titrant against the NCoA1 (257-370) in the cell.
The amount of STAT6 peptide was 20 times higher than that of NCoA-1(257−370) in the
cell, so that after the completion of the titration, there was twice as much STAT6 peptide
than NCoA-1 (257−370) in the cell.
2.3 Methods in NMR spectroscopy
In most of the experiments the sample concentration was around 0.3 mM. 50 mM PO4,
150 mM NaCl, and 1 mM DTT, pH 6.5 was the buffer condition for all measurements,
except for the cases where salt titration was done during alignment with the Pf1
phages. The temperature of measurement for the NCoA-1(257−420) fragment was 293
K. For all other experiments, the measurement temperature was 300 K. In the case of
measurement of samples containing bicelles however the temperature for measurement
was increased to 309 K. Table 2.4 shows the summary of all types of experiments
measured.
2.4 NMR experiments
Over the last 55 years NMR has developed from a description of a physical phenomenon
to a powerful tool to elucidate three dimensional structures of biomolecules in solu-
tion and solid state, their dynamics and the kinetics of their interaction with other
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Table 2.4: Summary of the NMR spectra measured on NCoA1
Protein Experiment Field strength in MHz Temp in degree Kelvin
NCoA-1(257−420) HNCA 600 293
HNCACB 600 293
CB(CA)CONH 600 293
HNCO 600 293
NCoA-1(257−385) HNCACB 700 300
NCoA-1(257−370) HNCA 600 300
HN(CA)CO 600 300
HNCACB 600 300
CBCA(CO)NH 600 300
HNCO 600 300
HNCO(TROSY) 600 300
IPAP 600, 800, 900 300
ECOSY-HNCO 800 300
biomolecules. This development of NMR has been possible due to three important
concomitant factors : (i) Availability of very high magnetic fields up to 24 T with a
spatial and temporal homogeneity of the order of 10−9. (ii) Development of powerful
computers that can control the radiofrequency preparation and excitation, with the
added ability to vary phases and amplitudes in any conceivable way. (iii) Development
of highly sensitive probes that facilitate the measurement of ample signals from samples
as low as 10−7 M in concentration.
2.5 Theoretical Basis of NMR Phenomenon
Four parameters are mainly used in NMR based structural elucidation of proteins and
nucleic acids [119] :
2.5.1 Chemical shift
Chemical shift is the property of nuclei to resonate in an external magnetic field at a
frequency that depends on the chemical environment. Thus, physically identical nuclei
such as the 1H , resonate at different frequencies in different chemical environments
. The chemical shift of nuclei also depends on the orientation of the molecule in
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the magnetic field. In isotropic conditions, where there is equal probability for the
molecules to take all possible orientations with respect to the magnetic field, only the
orientation-independent part is observed. There is a strong relationship between α-CH
1H chemical shifts and the protein secondary structure for all the 20 amino acids[120,
121]. It is a simple method which can be used in conjunction with other methods to
determine protein secondary structure. The method is almost entirely empirical. Early
studies by Clayden and Williams[121] suggested that strong conformation dependent
tendencies exist in chemical shifts in the case of α helices and β sheets. Figure 2.1
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Figure 2.1: Average chemical shifts for different nuclei in proteins, from Biological
Magnetic Resonance Bank (BMRB) database
shows the average chemical shift values for the commonly used chemical shifts of Cα,
Cβ and Hα and CO (carbonyl carbon) values.
2.5.2 J coupling
The J coupling is a scalar quantity, which is a measure of the interaction of two nuclei.
It is isotropic in nature and hence is independent of the orientation of the molecule with
respect to the external field. J couplings exist between covalently bonded nuclei. A J
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coupling is reflected as an internal splitting of a resonance line in the NMR spectrum.
The size of the J couplings depend on the involved nuclei, as well as the nature of the
bonds that connect the nuclei. When the nuclei are connected through only one bond,
the J sizes are predictable. The J coupling across single bonds is an unambiguous way
to infer constitution from connectivities. J couplings of nuclei connected through two
bonds and three bonds are represented as 2J and 3J and are also called as geminal and
vicinal couplings respectively. For proteins and nucleic acids with repetitive elements
correlations via single bonds are also the established approach. Completely replacing
the normal carbon nuclei with 13C and the nitrogen with 15N is required for this method.
For example, the whole protein molecule becomes a chain of NMR- active nuclei in
which each of the nuclei are connected by one bond at least to two others. The
correlation information is inferred by essentially relating the chemical shift information
of each nucleus within an amino acid to the amide 15N and 1H chemical shifts. The
coupling topology is represented for a segment of a protein chain, in the Figure 2.2.
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Figure 2.2: Coupling topology in polypeptides
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J couplings as a structural tool
3J coupling constants could be used as a direct source of information on torsional
angles, by the virtue of Karplus relation which allows the calibration of Karplus curves
for different molecules. There is almost no angle in biomolecules that cannot be defined
by coupling constants quite accurately. The magnitude of a 3J scalar coupling constant
is a function of the dihedral angle, θ, formed by the three covalent bonds :
3J = A cos2 θ +B cos θ + C. (2.4)
where the constants A, B, and C depend on the particular nuclei involved in the
covalent bonds[122].
2.5.3 Nuclear Overhauser Effect (NOE)
The NOE is the conventional parameter for structure elucidation. It describes the flow
of z-magnetization of a nucleus to a neighbouring one with a cross-correlated relaxation
rate σ. This rate depends on the distance between protons via the inverse 6th power,
as well as the diffusional rotation correlation time of the molecule.
σHH =
γ4H
10r6H,H
(
~µ20
4pi
)(−τc + 6 τc
1 + 4ω2Hτ
2
c
) (2.5)
where, γH is the gyromagnetic ratio of the proton, rH,H is the distance between the
interacting protons, µ0 is the permeability constant, and τc is the correlation time.
2.6 Basic Principles of Multidimensional NMR
NMR spectra of biological macromolecules contain hundreds and thousands of reso-
nance lines which are impossible to be resolved in a 1D experiment. For a detailed
analysis, accurately resolved lines are a prerequisite. Moreover, the interpretation of
NMR data requires correlations between different nuclei, which are difficult to extract
from 1D spectra. Multidimensional NMR spectra provide both increased resolution and
correlations, which are much easier to analyze. The important step in increasing the
dimensionality of NMR experiments lies in extending the spectrum from one to two
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dimensions. Spectra of higher dimensionality consist of a straightforward combination
of 2-D experiments.
Multidimensional NMR offers the following distinct advantages[123]: 1. Over-
crowding of resonances is avoided, as the spectral information is spread out in a plane
or a cube rather than along a single frequency dimension as in the 1D, 2. Correlation
of pairs of resonances. A 2D spectrum, S(ω1, ω2) is obtained from a two-dimensional
Fourier transformation of a time domain signal, s(t1, t2), that is a function of two
independent time variables, t1 and t2. 2D spectra are commonly presented as contour
plots, where contours are drawn through the points of equal intensity, analogous to
elevation lines on a geographic map.
A n-dimensional Fourier transform of S(t1,t2,...........tn) provides a nD spectrum
that depends on n frequency variables S(ω1,ω2,.....,ωn). If two nuclei suitably interact
within this mixing time this interaction will manifest as a cross peak, at a position
characterized by the resonances of the interacting nuclei. In principle, it is possible
to correlate additional physical parameters and to display 3D data in a cube, and 4D
NMR spectra can be displayed by spreading the data in each plane of the 3D plot into
a separate set of planes.
2.6.1 The basic 2D experimental procedure
In a typical 2D experiment, four time intervals can be distinguished[124]. 1. A
preparation period (τp) 2. An evolution period (t1) 3. A mixing period (τM) 4.
Detection period (t2). In many experiments, during the preparation period, the nuclear
spin system is allowed to come to equilibrium, while in some others, elaborate pulse
sequences may be used to ”prepare” the system for the rest of the 2D experiment.
The final step in the preparation period causes the magnetization M to be rotated
to the xy plane, by a simple 90◦ pulse, and occasionally by a more complex pulse
sequence. During t1, the magnetization evolves freely, so that Mxy precesses at its
Larmor frequency, and each nuclear magnetization is ”tagged” according to its Larmor
frequency, which depends on the particular Hamiltonian that is operative in the spin
system. The mixing period τM gives nuclear magnetizations in the xy plane a chance
to interact or ”mix” their wavefunctions. Finally, t2 is the usual data acquisition period
in which an FID is acquired, just as in an one dimensional experiment. This procedure
is repeated a large number of times, with different durations of the evolution period,
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keeping all other things a constant. For each value of t1, the signal recorded during
t2 is digitized and stored in computer memory. Upon completion of the entire 2D
experiment, a data matrix representing the two-dimensional time domain signal s(t1, t2)
is available in the computer memory. Two Fourier transforms, with respect to t1 and
t2 plus other data processing similar to that in one-dimensional NMR then provide the
desired 2D spectrum. A large number of 2D and multidimensional NMR techniques
are available and new variations are continuously being developed and improved. A
summary of the commonly used 2D experiments is provided.
2.6.2 Heteronuclear Single Quantum Coherence(HSQC)
In the heteronuclear single quantum coherence (HSQC) experiment[125], the INEPT3
(Insensitive Nuclei Enhanced by Polarization Transfer) sequence is used to transfer I
spin polarization into antiphase heteronuclear single quantum coherence. The an-
tiphase heteronuclear coherence evolves during the subsequent t1 evolution period.
A second INEPT sequence is used to transfer the frequency-labeled heteronuclear
coherence back to proton magnetization for detection. This is one of the most sensitive
of the 2D experiments.
2.6.3 Measurement of J and D couplings
IPAP-HSQC (In Phase Anti Phase HSQC)
In this method[126] two spectra are recorded in an interleaved manner, one with in-
phase doublets and another with anti-phase doublets. Upon addition of the two spectra,
a 1HN -15N correlation spectrum showing only the upfield or downfield component of
the 15N doublet is generated. There are lesser resonance overlaps relative that of the
decoupled HSQC spectrum.
2.6.4 Novel sensitivity enhanced experiments
In addition to the large one bond 15N -1H dipolar couplings, backbone one bond 15N -
13CO and two bond 1HN -13CO dipolar couplings play vital roles in protein NMR, inspite
3A basic unit of a complex NMR pulse sequence; explanation beyond the scope of the thesis. A very
useful scheme for obtaining better S/N ratio with samples of very low concentration
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of their small values. In order to measure the one-bond NCO couplings and the more
difficult to obtain, two bond HCO couplings from NCoA1, a recently developed E-COSY-
HSQC type experiment [127] was used. It is difficult to implement J-correlation type
experiments for the measurement of two bond 1HN -13CO couplings. In a classical
E-COSY experiment, both couplings can be measured in a single spectrum, but the
E.COSY introduced splitting causes a decrease in the resolution and the sensitivity of
the spectrum. In the novel E-COSY type HSQC experiment, one bond 15N -13CO and two
bond1HN -13CO couplings are obtained from two spectra by a complex combination of
splittings. Manipulation of the E-COSY split pair in a echo-antiecho fashion correlates
the frequencies of the low field and high field peaks of the E.COSY doublets with the
proton and nitrogen frequencies. This manipulation results in twice the number of
scans leading to a 1.4 times increase in sensitivity.
2.6.5 Three Dimensional NMR
A 3D pulse sequence can be obtained from two separate 2D experiments by deleting
the detection period, of one experiment and the preparation period of the other, to
obtain two evolution periods (t1 and t2), and one detection period t3. Conventional 3D
assignment is by NOE connectivities between adjacent residues involving NH, CαH and
CβH protons. The same approach can be used in 3D NMR.
Sequential Assignment Via One-Bond J Couplings
Triple resonance experiments can be used to sequentially assign the backbone NH, 15N ,
13Cα ,13CO and CαH resonances by means of heteronuclear one-bond couplings without
any knowledge of the spin systems involved. This involves the measurement of 6
different kinds of spectra namely the HNCA, HN(CA)CO, HNCO, HN(CO)CA, HNCACB,
CBCA(CO)NH. The nomenclature for triple-resonance experiments is systematic. The
frequency labeled spins during acquisition in the indirect evolution periods or the
acquisition periods are listed using HN, N, HA, CA, CO, HB, and CB to represent the
1H , 15N , 1Hα , 13Cα , 13CO , 1Hβ and 13Cβ spins respectively.
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Figure 2.3: The HNCO experiment
HNCO
The 3D HNCO experiment[128] correlates the NH and 15N chemical shifts of residue
i with the 13CO shift of the previous residue through the one-bond 1J NCO coupling
of 15 Hz, thereby providing sequential connectivity information. In this experiment,
magnetization originating from the amide protons is transferred to the directly bonded
15N spins using an INEPT sequence, following which the 15Nmagnetization evolves
exclusively under the influence of the 15N as a result of 1H -13CO and 13Cα decoupling
through the application of the 180◦ pulses at the midpoint of t1 interval. During
the delay δ 15Nmagnetization becomes antiphase with respect to the polarization of
the carbonyl spin of the preceding residue via the 1J NCO coupling and the subse-
quent 90◦ 13CO pulse converts this magnetization into 15N - 13CO two spin coherence.
Evolution of the 13CO chemical shift then occurs during the period t2, and the con-
tributions of 15N chemical shift and 1H -15N 1J coupling on the one hand, and of the
13Cα -13CO 1J coupling on the other, are removed by the application of 180◦ 15N and
13Cα pulses, respectively, at the t2 midpoint. Magnetization is finally transferred to back
to the NH protons by reversing the transfer steps and detected during t3.
HNCA
The HNCA experiment[128] correlates the 1H and 15N chemical shifts with the 13Cα of
the same residue. The one bond 15N -13Cα J coupling is exploited to correlate 15N and
13Cα spins. The magnetization is also transferred from the 15N spins to the 13Cα of the
preceding residue through the interresidue two bond 15N -13Cα J coupling, which can
be as large as 9 Hz[128, 129].
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Figure 2.4: The HNCA experiment
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Figure 2.5: The HNCACO experiment
The HN(CA)CO experiment[130] provides correlations between the amide 1H ,
15N and 13CO chemical shifts by using the one-bond 15N -13CO J couplings for coherence
transfer[130]. This experiment provides sequential connectivities from the 15N spins to
the 13CO of the previous amino acid through the interresidue two-bond 15N - 13Cα J
coupling.
HNCACB
The HNCACB experiment[129] correlates the 13Cα and 13Cβ resonances with the amide
1H and 15N resonances of the same residue and the amide 1H and 15N resonances of the
succeeding residue through 1JCN and 2JCN couplings, respectively. In addition to the
sequential connectivities the 13Cα and 13Cβ chemical shifts provide information on the
amino acid type. The 13Cβ is not present in the strip containing the Glycine and its
subsequent residue as the Glycine does not have a 13Cβ spin. The HNCAB spectrum is
very helpful in resolving ambiguities, as it provides sequential resonance information
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Figure 2.6: The HNCACB experiment
using two possible sequential connectivities. Some residues are very conspicuous in a
HNCACB spectrum as they have characteristic resonances.
CBCA(CO)NH
The CBCA(CO)NH experiment[129] correlates both the 13Cα and 13Cβ resonances of
an amino acid residue with the amide 1H and 15N resonances of the following residue.
These correlations are highly useful if significant 13Cα -1Hα chemical shift degeneracy
exists. The interresidue correlations are established by transferring coherence through
the intervening 13CO spin.
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Figure 2.7: The CBCACONH experiment
In case of a 13Cα - 1Hα degeneracy, this correlation is useful. 13Cα and
13Cβ resonances provide information on the type of amino acid preceding the amide.
The interresidue correlations are established by transferring the coherence through the
13CO spin.
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Chemical Shift Index
The chemical shift index calculation is a simple method of estimating the secondary
structure, based on NMR resonance assignment data[120]. Typically,
CSI = δCB − δCA, (2.6)
where δ CA = Cαrandomcoil - Cαexpt. and δ CB = Cβrandomcoil - Cβexpt..
HNCO-TROSY
Two main problems limit the study the large molecules using NMR. First, the large
number of signals that arise causes increased resonance overlap, which makes the
intrepretation of spectra very difficult. Second, large molecules relax faster, which
leads to increased line broadening and subsequently poor resolution of the spectra. In
theory, the resonance overlap problems can be reduced by a suitable isotope labeling
scheme [131], but the limitation due to faster relaxation is a more severe challenge.
The hydrogen atoms, which constitute a major source of relaxation also provide the
most sensitive NMR signal and therefore valuable structural information. Therefore,
their replacement by deuterium ions to substantially reduce transverse relaxation, is an
option. Even this fails when the size of the molecule extends beyond 50 kDa. Transverse
Relaxation Optimized Spectroscopy (TROSY)[132], uses spectroscopic means to reduce
relaxation, and is suitable for large molecules as it reduces the relaxation to such an
extent that satisfactory linewidths could be obtained and sensitivity enhanced.
Theory of TROSY
1H spins are scalar coupled to 15N nuclei which gives rise to a proton spectrum where
there are two peaks - one from those protons which are spin up with respect to 15N and
another from those protons which are in spin down status. In a large molecule, the
two lines have very different line widths. The two lines are collapsed by decoupling in
conventional NMR, with the compromise of averaging the relaxation rates. The signal
will be much more attenuated in the case of larger molecules because one of the peaks
will arise due to faster relaxation. The TROSY technique is used to exclusively select
the slower relaxing peak neglecting the faster relaxing peak. The loss of half of the
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potential signal is compensated for, during acquisition.
2.6.6 Sequential Resonance Assignment
All spectra were processed by NMRPipe software from the NIH[133]. The processed
spectra were analyzed using Felix (Accelrys) or Sparky (Computer Graphics Lab, Uni-
versity of San Francisco) NMR data analysis programs. Analysis consisted of initial
peak picking and cleaning noise from the peak lists of different spectra. The peak
list was verified and was used for manual assignment of the resonances. Sequential
resonance assignment was also performed using the program MARS developed in the
department. Resonance assignment results were output by the program in a Sparky
compatible format. The output was once again read into Sparky program and cross
checked.
2.7 Residual Dipolar Couplings(RDCs)
Dipolar couplings are the dominant interactions in solid state NMR of spin nuclei, they
are averaged to zero for isotropically reorienting molecules in the liquid state[134,
135]. This makes it possible to achieve high resolution in liquid state NMR[136].
On the other hand, a wealth of structural information is lost, if the couplings
disappear[137, 135]. Even in liquid state NMR, molecules can be weakly aligned,
e.g., by external fields, or by anisotropic solvents [138, 139, 140, 141, 134, 135].
Dipolar couplings are potentially large interactions, caused by the magnetic flux lines
of one nucleus affecting the magnetic field at the site of another nucleus[135].
In the Figure 2.8, nuclei P and Q are part of a molecule in solution and ~r is the
internuclear distance separating them. In the lab frame the vector representing the
magnetic field, ~B0, is constant whereas the internuclear vector is time dependent as a
result of molecular tumbling. For simplicity it is assumed that the molecule is rigid and
hence there is no internal dynamics. Therefore, the magnitude of r is also a constant.
The component parallel to the magnetic field ~B0 is the only component of concern,
since the components perpendicular to the ~B0 magnetic field have a negligible effect
on the total magnitude of the vector sum of the external and the dipolar field. The
z component of the dipolar magnetic field of the nucleus P will change the resonance
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Figure 2.8: In the lab frame, the magnetic field vector ~B is constant (pointing along the zL
axis) but the internuclear vector is time dependent
frequency of nucleus Q by an amount that is dependent on the internuclear distance
and on the orientation of the internuclear vector relative to ~B0. For a fixed orientation
of the vector, which is parallel to ~B0, nuclear spin P can increase or decrease the total
magnetic field at nucleus Q, depending on whether P is parallel or anti-parallel at ~B0.
In a molecular ensemble, half of the nuclei will be parallel to ~B0, and other half will be
anti-parallel. Spin Q will show two resonances (doublet), separated in frequency by
DPQ = DPQmax〈(3cos2θ − 1)/2〉 (2.7)
where θ is the angle between the internuclear vector and B0, and the 〈〉 brackets denote
ensemble averaging over time. Equation 2.7 shows that the dipolar splitting, DPQ
provides direct information on the angle θ, i.e., on the orientation of the internuclear
vector, and that it is proportional to the inverse of the cubed internuclear distance.
Under isotropic conditions, rotational Brownian diffusion rapidly averages the internu-
clear dipolar interaction to exactly zero. As a result, the solution NMR spectrum shows
narrow resonances, which can be assigned to individual nuclei in the protein, but which
no longer contain valuable orientation information. In solids, such an averaging does
not take place, and each nucleus couples with a very large number of other nuclei
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(each of which can point parallel or anti-parallel to the magnetic field), resulting in
unresolvable, very broad resonances. Mechanical rotation of the sample around an axis
that makes an angle of 54.7◦ with the B0 magnetic field, together with a radiofrequency
irradiation, can be used to average the dipolar interaction to zero and reintroduce
sharp features in the NMR spectrum [142]. In an intermediate case where, the protein
is dissolved in a slightly anisotropic aqueous medium, where not all orientations of
the protein have an equal chance of occurrence, the alignment of the protein can be
described by an alignment tensor, ’A’. This tensor is a real symmetric matrix, which can
be diagonalized. In the corresponding molecular frame for the tensor ’A’, its principal
components A’xx,A’yy, A’zz reflect the probabilities for the x,y, and z axes to be parallel
to B0(Figure 2.9(a) and (b)). The difference among A’xx,A’yy, and A’zz contributes to
dipolar coupling. Therefore the alignment matrix is used in its traceless form, A. When
Azz, Ayy, and Axx are defined, the dipolar coupling depends on the polar coordinates of
the P-Q vector in the frame of the diagonalized alignment tensor in the following way :
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Figure 2.9: (a) Depiction of the orientation of the internuclear vector and the magnetic field
relative to a molecule fixed frame. The time dependance of the magnetic field vector arises
due to molecular reorientation. (b) The three angles θ, φ, ψ called the Euler angles describe the
overall molecular alignment (Ax, Ay, Az)relative to a principal axis system.
DPQ(θ, φ) = 3/4DPQmax[(3 cos
2 θ − 1)Azz + sin2 θ cos 2φ(Axx − Ayy)] (2.8)
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where, θ
This equation can also be written as,
DPQ(θ, φ) = Da[(3 cos
2 θ − 1) + 3/2R sin2 θ cos 2φ] (2.9)
where Da = 3/4DPQmaxAzz is referred to as the magnitude of the dipolar coupling
tensor, usually normalized to the N-H dipolar interaction, and R = 2/3(Axx − Ayy) is
called the rhombicity.
Equation 6.3 indicates that for a given value of DPQ there can be an entire cone of
(θ, φ) solutions that correspond to this dipolar coupling. So, the dipolar coupling does
not define an unique orientation for the internuclear vector but restricts it to be on the
surface of a distorted cone. The inverted vector orientation QP also gives rise to the
same coupling, and an inverted cone is also included in to the solutions to equation
6.3.
2.8 Alignment in liquid crystals
Intermolecular complexes, mutidomain proteins and nucleic acids that are more dif-
ficult to study than globular proteins, because of comparatively low intensities of
meaningful Nuclear Overhauser Effects (NOEs), are now far more accessible to ex-
perimental characterization in solution. The measurement of relatively small sets
of RDCs can allow pH and/or temperature dependent shifts in conformation to be
detected, binding interfaces to be characterized and rapid establishment of relative
orientation in solution [143]. The wide timescale sensitivity of RDCs to molecular
motions (<10−3 seconds) allows experimental accessibility, at atomic resolution, to
functionally important motions occurring in the nanosecond to microsecond time scale.
Apart from the necessity of finding an alignment medium that is compatible with the
molecule under relevant solution conditions, the nature of molecular alignment can
vary according to the physical properties of the medium used. In the past few years,
there is a rapid development in RDC techniques to quickly establish the average solution
state conformations of intermolecular complexes or the relative orientation of domains.
RDCs can be used to probe the conformations of these systems in solution without
carrying out a complete structure determination, in the assumption that the distinct
structural elements estimated a priori are rigid entities. NMR plays a complementary
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role to crystallography, as the RDC constraints are used to refine global arrangement
of these structural elements, which originate mostly from crystallographic studies.
Several procedures have been described in order to make such a refinement, such
as order tensor analysis [144] or rigid body minimization [145] but they all have a
fundamental similarity in that the orientations of the partners involved are optimized
by a best fit to the RDC data. A whole array of liquid crystalline solvent systems
useful for inducing molecular alignment of macromolecules have been introduced. The
rapid translational diffusion eliminates intermolecular dipolar interactions, but large
intermolecular dipolar couplings can be seen.
2.9 Application to structure calculation and structure
validation
The quality factor Q[146] is a convenient criterion to validate the compatibility be-
tween structures and RDCs measured in solution.
Q = rms(Dcalc −Dobs)/rms(Dobs) (2.10)
where Dobs and Dcalc are observed and calculated one-bond dipolar couplings. It is
important that the couplings used in the evaluation are not used in the structure
calculation process, which would make the validation meaningless. In order to pre-
dict the dipolar couplings using equation 6.3, the magnitude and orientation of the
alignment tensor need to be known. There are two ways to obtain this : 1. It can be
predicted from the molecular shape[147] 2. Using singular value decomposition[144],
the alignment tensor that best fits with the experimental data can be found. There
are five independent parameters in such a fit, and it is hence important in Q factor
evaluations that the number of fitted dipolar couplings is very much larger than five.
Structure determination based on existing structures
The conventional method of structure determination by NMR relies on short-range
interproton distances (NOEs). When applied to larger proteins or more complex
systems this method encounters severe limitations. RDC data have been used to
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determine relative orientation of multidomain macromolecules using rigid body mod-
eling assuming a common alignment tensor and have been shown to decrease the
disorder present in NMR structural ensembles when combined with NOEs. RDC
measurements have been successfully used to predict the backbone conformation of
protein in solution. The molecular fragment replacement (MFR) method [148] is
analogous to a method proposed by Kraulis and Jones for determining local structures
of protein fragments and is similar to the database approach for fitting the main chain
electron density of protein X - ray structures. This method has been demonstrated in
ubiquitin. Four backbone couplings namely the N-H, the C’-N, the C’-HN and Cα - Hα
were measured. A fragment size of 7 residues was used and for each fragment the best
fit between its set of measured dipolar couplings and each 7 residue fragment found in
the Brookhaven Protein Data Bank (PDB) is determined by using a linear least squares
method.
2.10 Alignment of NCoA-1(257−370) Using Pf1 Phages
Much effort has been directed towards development of alignment media that are stable
over a wide range of pH and temperature and that have a minimal adverse effect on
rotational diffusion. [149]. Availability of multiple media is useful as it allows for mea-
surement of residual dipolar couplings in different alignment frames [150, 151]. The
combination of disc shaped bicelles [152] and rod-shaped virus particles is particularly
useful in this regard [153]. Two different mechanisms of interaction, steric for neutral
bicelles and mainly electrostatic for phage, generally result in linearly independent
alignment tensors [154]. But, bicelle liquid crystalline phase is unstable in the presence
of certain proteins and offers only a limited temperature range [126]. Phage particles
are highly negatively charged and can bind non-specifically to macromolecules that
have a significant positively charged surface patch. Pf1 phage from Profos Biolabs
(Munich) was used for alignment. The phage was added to the wall of the NMR sample
tube with the sample. The top of the tube was closed using parafilm and the tube was
inverted up and down many times, so that phage and the protein sample mixed well.
The protein sample with the phages was centrifuged slightly to remove the air bubbles.
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2.11 Alignment of NCoA1(257−370) Using Bicelles
A few years ago, application of liquid crystal NMR techniques were extended to
some larger, biologically relevant molecules with the aid of isotopic labeling and a
medium comprised of an aqueous dispersion of lipid bilayer disks (most commonly a
mixture of dimyrystoylphosphatidylcholine and dihexanoylphosphatidylcholine, DMPC
and DHPC) [155]. However, the use of bicelle solutions to orient different molecules is
not problem free. At low concentrations of solutes the samples often phase separate or
become isotropic in times short compared to normal data acquisition times. Instabilities
seem to be aggravated by the presence of buffers and electrolytes needed to maintain
native structures of biomolecules [156]. Addition of small amounts of charged am-
phiphiles to normal bicelle preparation can avoid some of these instabilities and extend
the range over which these preparations maintain a useful degree of orientation and
homogeneity [157]. Water in the medium provides a probe of orientation if some
water protons are replaced with deuteriums. Deuterium has a quadrupolar nucleus that
interacts with both the laboratory magnetic field and the local electrical field gradient.
The electric field gradient interactions add an anisotropic perturbation that splits the
normally degenerate resonances of a deuterium nucleus. Under isotropic tumbling,
these splittings average to zero. In the presence of bicelles, a small quadrupolar
coupling results from the fast exchange of bulk solvent, that is isotropic and the
solvent associated with the bilayer, which is partially oriented. Spectra as a function
of temperature were measured. The starting temperature was 25 ◦C and it was
raised by two degrees at each step. The sample was allowed to equilibrate at the
desired temperature for at least 10 minutes prior to acquisition of the spectra. A
DMPC:DHPC::3.2:1 ratio was used at 36◦C. The sample was allowed to equilibrate
at 306 K for 10 minutes.
2.11.1 Preparation of bicelles
A premixed powder containing DMPC and DHPC in the ratio 3.2:1 was obtained from
Avanti Polar Lipids, Alabama. A 15% w/v solution was made using NMR buffer at pH
6.5. The lipid mixture was hydrated by many cycles of freezing and thawing on ice
and 38◦ C respectively, with vigorous vortexing. The sample was incubated on ice for
10 minutes and then vortexed at room temperature, heated at 38◦ C for 10 minutes
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and vortexed at room temperature. This cycle was repeated six times until the solution
reached a stage where it was a clear transparent fluid at lower temperature, milky at
about 25◦C and transparent but viscous at 38◦C. There was a slight bluish tint. At this
stage, 2 times protein solution was mixed with 1 times bicelle solution to get a 5 %
w/v bicelle sample for NMR. The protein solution contained 15% D2O so that the final
content of D2Owould be 10% of the total volume. 200 µl of the sample that contained 5
% bicelle solution, 15% D2O was added to a Shigemi (Shigemi Corporation, Tokyo). The
probe was preheated to 308 K and the splitting of D2O was observed in a few minutes.
At 308 K, a splitting of 7 Hertz was observed. A HSQC spectrum was measured at
this temperature. A comparison with the HSQC spectrum measured at 300 K ( the
temperature at which all other types of experiments were measured), did not show
any shift of peak position due to a shift in temperature. However, the signal from the
modified HNCO-TROSY[158] type experiment failed to show a S/N ratio comparable
to the HSQC. It was assumed that this difference in signal could be because of the
interaction between the protein and the bicelles. After a few hours, when the sample
was removed out of the magnet, there was phase separation inside the NMR tube,
where the bicelles settled as white fluffy mass in the lower part of the NMR tube. This
condition was reversible upon vigorous remixing, but the behaviour repeated in a few
hours again. This condition is not suitable for measurement of spectra over prolonged
periods of time. Therefore a stabilizing agent Cetylpyridinium Tetraethyl Ammonium
Bromide (CTAB) was added at 0.7 mM final concentration.
2.12 Alignment using polyethylene glycol/hexanol
based medium
A non-ionic liquid crystalline medium, [149] was used for alignment. This medium
consists of an n-alkyl poly(ethylene glycol)/n-alkyl alcohol mixture and is known as
the Otting Phase. C12E5 is the polyethylene glycol component and hexanol is the n-
alkyl alcohol [159, 160, 161]. This medium belongs to a class of liquid crystals which
are uncharged, insensitive to pH, fairly insensitive to salt, feature little or no binding
capacity to macromolecules, and can be used at temperatures below 0◦ C up to 40◦ C,
covering the temperature range of interest for most NMR studies of macromolecules.
Under certain conditions, this system forms a lyotropic liquid crystalline phase, where
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the hydrophobic n-alkyl chains aggregate into planar bilayers with the hydrophilic
polyethylene glycol headgroups directed into the water phase. This phase, called the
Lα phase, is optically clear, with slight opalescence, has a lamellar-like super structure.
The spacing of the stacked bilayers and hence the arrangement of protein molecules
in the water rich layers can be tuned by adjusting the surfactant to water ratio. The
spacing can range from several hundred nanometers (1 wt %) to a few nanometers in
the more concentrated regime (>5 wt%). In the magnetic field, the bilayer surfaces
are oriented parallel with respect to the direction of the magnetic field [155] possibly
with a superstructure in which the bilayers bend into a set of concentric tubes with
the axis aligned along the field. At high surfactant concentrations (>50 %) and
temperature (>50 ◦ C), the liquid crystalline phase is already formed by binary mixture
with alcohol. The addition of n-alkyl alcohols lowers the temperature range of stability
for the liquid crystalline phase and makes the lyotropic phase accessible even at low
surfactant concentrations [159].
2.12.1 Preparation of the Otting Phase
A 5× stock solution (25 % w/v of the polyethylene glycol C12E5) of the Otting Phase was
made by taking 130 µl of C12E5 in a clean Eppendorf tube and votesting well with 370 µl
of 90 % H2O/10 % D2O solution. The resulting mixture was clear and viscous. To this,
hexanol was added in microlitre steps. After addition of 15 µl of hexanol, the solution
turned turbid and the addition of hexanol was continued in one micro-liter steps. When
the total amount of hexanol reached 18 µl the solution turned clear with a bluish tint.
Two more mico-liters of hexanol were added to this in order to compensate for the loss
of hexanol by evaporation. The final ratio of C12E5/ hexanol was 1:0.96 (w/w). The
phase remained in this state, even after vigorous vortexing and centrifugation. This
stock solution was diluted to 5% C12E5 by adding protein solution containing 10% D2O.
There was a slight disturbance in the phase, but the mixture became clear by addition
of just one µl of hexanol. But this was not stable for more than 10 minutes as a white
precipitate was observed after this time.
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2.13 Polyacrylamide Gels in Alignment
Polyacrylamide gels provide an alternative approach to the preparation of weakly
aligned samples of membrane proteins. This method is called strain induced alignment
in gel (SAG)[162, 163]. The method is based on the fact that either radial or vertical
compression of the gel alters the pore shape and induces preferential alignment of
the protein[164]. Polyacrylamide gels are chemically inert with respect to the solute
proteins, the samples are stable over a wide range of temperature, ionic strength and
pH and even allow the study of proteins in partially or fully denatured conditions [165].
Several gels were cast using the apparatus as mentioned in a previous work[164]. The
polymerized gels were washed several times using double distilled H2O, cut into rods
of 2 mm length and dried. Part of the drying was done in a desiccator and the rest
was carried out by storing the gels overnight at 8 ◦C. A completely dried gel without a
mechanical flaw was chosen and transferred to a shigemi tube. Five hundred microlitres
of protein solution of 0.4 mM concentration was added to the gel and closed with the
plunger. The protein was allowed to diffuse into the gel overnight. The swollen gel was
measured for D2O splitting. There was a splitting of 10 Hz, but the proton spectrum
showed very broad lines from the protein. A HSQC spectrum of the sample showed
only a few peaks from the backbone amide residues and the side chain peaks.
2.14 Alignment trials using paramagnetic tags
Protein molecules which are intrinsically diamagnetic do not show enough alignment
in a strong magnetic field, and it was one of the reasons for the introduction of
external alignment media. However, paramagnetic molecules do not require external
alignment media[141]. Structural restraints such as paramagnetic relaxation as well
pseudocontact shifts can also be obtained from such molecules in addition to dipolar
couplings when they are placed in high magnetic fields. Diamagnetic proteins can be
converted to paramagnetic proteins by attaching a paramagnetic tag, which is a small
organic molecule that specifically binds a lanthanide [166]. Certain derivatives of EDTA
can be used for this purpose, as they have sub-picomolar dissociation constants, for
lanthanides in neutral pH. The tag was added in 3 times in molar excess to 0.1 mM of
NCoA-1(257−370) in 50 mM MOPS buffer, pH 6.5, 150 mM NaCl and incubated overnight
56 Chapter2. Materials and Methods
at room temperature.
2.15 Titration experiments
Chemical shift perturbation is the most widely used NMR method to map protein
interfaces. The 15N-HSQC spectrum of one protein is monitored when the unlabeled
interaction partner is titrated in, and the perturbations of the chemical shifts are
recorded. The interaction causes environmental changes on the surface of the protein
interfaces, and therefore the chemical shifts of the nuclei in this area. In some cases,
the entire protein may shift conformation and all the shifts may be affected. Then the
chemical shift perturbation fails as a mapping technique, but is a very good indicator
of allosteric processes [167, 168]. Chemical shift perturbations are sensitive to very
subtle effects. To quantify the shift perturbation, most workers use the length of the
vector that connects the two-dimensional end points, normalized by typical shift ranges
[169]. The precise values of these normalization factors are not important, because of
the complicated relationship between structure and chemical shift [170]. The results
are significant when a contiguous surface patch of shifting resonances are obtained.
Titrations allow a good estimation of affinity, specificity of binding as well as the kinetics
of binding. The kinetics of the interaction determine how the chemical shifts of the
labeled protein change during the titration. If the dissociation of the complex is very
fast, there is only a single set of resonances even during the titration. The chemical
shifts are the weighted average of the chemical shifts of the free and bound form.
The resonances of the nuclei at the interface move in a continuous manner during the
titration. This regime is referred to as fast chemical exchange and is often observed
for weaker interactions. If the complex dissociation is very slow, there are two sets
of resonances, one for the bound form of the protein and the other for the free form.
The set of resonances corresponding to the free form will disappear during titration
and will be replaced by those from the bound form. Most of the resonances of the two
sets will overlap with each other but the differences will mark the interaction interface.
In the case of slow exchange it is not known to which new location the resonance has
moved unless there is an independent assignment of the bound form. Therefore it is not
easy to quantitate the degree of change. Some workers have approached this problem
by assuming that the new resonance which appears closest to the one from the free
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form corresponds to bound state [171, 172]. To account for the intrinsic differences in
chemical shift dispersion of 1HN, 15N, and 13C nuclei, was defined thus:
δ = (∆δ1HN/3.5) + (∆δ/30) (2.11)
Titration experiments were performed with all the three constructs of the NCoA-
1 namely the NCoA-1(257−420) , the NCoA-1(257−385) and the NCoA-1(257−370) fragments
with the STAT6(794−814) peptide. In the case of NCoA-1(257−420) , STAT6(794−814) peptide
was added to the protein sample such that the molar ratio of the protein to the
STAT6(794−814) peptide was 1:1. With the NCoA-1(257−385) fragment, the peptide was
titrated such that molar ratio of the protein to the peptide was 5:1, 2:1, 1:1 and 1.5:1.
STAT6(794−814) peptide was titrated into the NCoA-1(257−370) sample such that molar ratio
of the protein to the peptide was 1:1, 1:2, 1:3 and 1:4. The conditions of measurement
were maintained constant throughout the titration process.

Chapter 3
Results
3.1 Results from Biochemical and Biophysical Experi-
ments
3.1.1 Protein Expression and Purification
The expressions were carried out in different media, namely the Luria Bertani Medium
(LB), minimal medium with M9 salts, and a commercial medium, Silantes. Table 3.1
gives the yield from different media. The yield of NCoA-1(257−420) in LB medium was
around 12 mg, after the final step as calculated from UV280nm absorption from one litre
of the medium. In order to make an isotope labeled sample, however, the bacteria
were grown in minimal medium, with M9 salts (see Table 2.1). But the yield in this
medium was negligible when compared to that from LB medium. Since the loss during
concentration of the protein has to be taken into account, sufficient quantity of protein
is required before concentration. Therefore, the expression level was checked in a rich,
isotope labeled medium, Silantes (O.D. 2) R©, marketed by Silantes GmbH, Munich,
Germany. As seen from the Figure 3.1, the solubility of the NCoA-1(257−420) when
expressed using this medium was comparable to the results from LB medium. The
reason for poor solubility in minimal medium expression is not clear.
Figure 3.1 shows the expression profile of the NCoA-1(257−420) fragment in Silantes
medium. Figure 3.3(a) shows the elution profile of NCoA-1(257−370) after the histidine
tag was removed. The level of purity of the protein samples is seen in the gel. It
is the purity level of samples used for NMR measurements. Figure 3.3(b) shows the
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Type of Medium LB Minimal medium Silantes
final protein yield (mg/liter) 12 1 14
Table 3.1: Comparison of yield of NCoA-1(257−420)from expressions in different media
1 2 3 4 5 6 7 8 9 10
NCoA1(257-420)
150
100
75
50
37
25
15
kDa
Figure 3.1: A comparison of the expression of NCoA-1(257−420) in different media. 1. Broad
range protein marker. 2. Control - cell extract from uninduced cells (45 µl of the cells were
taken from the uninduced culture and boiled with 15 µl of 4 × SDS buffer, out of which 10
µl was loaded. 3. cell extract from cells 6 hours after induction. 4 and 5. insoluble fraction
and soluble fractions of the NCoA-1(257−420) from 22 ◦C induction in minimal medium with 1
× m9 salts. 6 and 7. insoluble fraction and soluble fractions of the NCoA-1(257−420) from 28
◦C induction in minimal medium with 1 × m9 salts. 7 and 8. insoluble fraction and soluble
fractions of the NCoA-1(257−420) from 28 ◦C induction in LB medium. 9 and 10. insoluble
fraction and soluble fractions of the NCoA-1(257−420) from 28 ◦C induction in Silantes medium.
Note that the protein is completely soluble when LB and Silantes were used, and the expression
levels are comparable. Amount of medium (100 ml) and time of induction were equal in all
cases.
sample purified after gel filtration. The second step of purification after TEV proteolysis
removes many other impurities in protein samples which can be seen in the gel Figure
3.3 (a) (Lane 3. resin sample).
3.1.2 Gel Filtration
Figure 3.4 shows the results of the gel filtration experiment of the NCoA-1(257−420) in
complex with the STAT6(794− 814) peptide. The fractions under absorption peak at
280 nm were collected and analyzed. N-terminal sequencing by Edman degradation
and MALDI analysis revealed that the STAT6(794−814) peptide, which is of a much smaller
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Figure 3.2: Large Scale purification of NCoA-1(257−420) in Silantes medium. 1. Broad Range
Marker. 2-10. Elution with elution buffer A. 11-15. Elution with elution buffer B.
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Figure 3.3: (a) Removal of the histidine tag after passing the sample through the Ni-
NTA column. Lane 1. Undigested control. Lane 2. Resin sample. Lane 3. Flowthrough.
Lanes 4-11. Wash with 1 ml of dialysis buffer. (b) Purity of the NCoA-1 (257-370)
sample after gel filtration. Lane 1. Broad range marker. Lanes 2-5 Sample after gel
Filtration.
molecular weight than the protein co-migrated with the NCoA-1(257−420) fragment and
the peptide and the protein were in a 1:1 molar ratio. Macromolecules are separated
during gel filtration because of the fact that bigger molecules elute faster than smaller
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Figure 3.4: Chromatograph of a gel Filtration experiment showing the elution profile of the
NCoA-1(257−385) in complex with the STAT6 peptide.
molecules. Since the peptide co-eluted with the protein it is clear that the peptide was
in a stable complex with the protein. This experiment showed that a stable complex
between the NCoA-1 and STAT6(794−814) could be reconstituted in vitro and the binding
was strong, as it could withstand the gel filtration step.
3.1.3 Secondary Structure Prediction
Secondary structure prediction was done by using the program SOPMA[173]. The
prediction showed that amino acids C- terminal of Asp366 formed a random coil.
3.1.4 Limited Proteolysis
Trypsin digestion revealed that the NCoA-1(257−385) was the most stable fragment as
expected from secondary structure prediction.
Figures 3.5 and 3.6 show the SDS polyacrylamide gel analysis of the samples taken
from different trials of limited proteolysis on the complex of NCoA-1(257−420) and STAT6
peptide and free NCoA-1(257−420) , respectively. The NCoA-1(257−420) complexed with
STAT6(794−814) peptide, and the protein blot corresponding to the band in lane 10 was
cut out for sequencing by Edman degradation. Corresponding protein sample was
also analyzed by mass spectrometry. The fragment had a mass of 14,795 daltons.
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Partially digested
Fragment after prolonged digestion
Figure 3.5: Limited proteolysis of the NCoA-1(257−420) fragment in complex with the STAT6
peptide. 1. Broad Range Marker. 2. Undigested control. Lanes 3,6,9 and 13 show proteolysis
carried out for 10, 30, 60 and 120 minutes respectively with a protease/protein ratio of
0.004(w/w). Lanes 4, 7, 10, and 14 show proteolysis carried out for 10, 30, 60 and 120
minutes respectively with a protease/protein ratio of 0.002(w/w). Lanes 5,8,12,15 show
proteolysis carried out for 10, 30, 60 and 120 minutes respectively with a protease/protein
ratio of 0.001(w/w). The digestion was stopped by immersing the samples in liquid nitrogen.
While part of the samples were used for mass spectroscopy, the bands on the gel were blotted
on a PVDF membrane and the bands were cut out for protein sequencing.
Sequencing results showed that the N- terminus of this fragment was the same as
that of the NCoA-1(257−420) fragment, thus verifying the identity of the protein. Based
on the secondary structure prediction which showed that the amino acids C-terminal
to Asp366 as disordered and limited proteolysis results where it was found that the
NCoA-1(257−385) was the most stable fragment, two new constructs, NCoA-1(257−370) and
NCoA-1(257−385) were designed and cloned into a pET16b vector.
3.1.5 Circular Dichroism
Both the free state NCoA-1 as well as the domain bound to STAT6(794−814) peptide were
analyzed with circular dichroism. The CD spectrum of STAT6 peptide alone was also
measured. While there was no significant difference between the bound and the free
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Figure 3.6: Limited proteolysis the free NCoA-1(257−420) fragment. Lane 1. Broad Range
Marker. Lanes 3,4,5, and 6 show proteolysis samples with a protease/ protein ratio of 0.004
where the digestion was carried out for 10, 30, 60, and 120 minutes respectively. Lane 7.
Proteolysis sample with protease/protein ratio of 0.002 where the digestion was carried out for
10 minutes. Lane 8. Undigested control. The digestion was arrested by immersing the samples
in liquid nitrogen. While part of the samples were used for mass spectroscopy, the bands on the
gel were blotted on a PVDF membrane and were cut out for protein sequencing.
NCoA-1 in the case of all the three fragments. Figure 3.7 shows the overlay of the CD
spectrum of the bound and free form of NCoA-1(257−370) fragment. The STAT6(794−814)
peptide alone showed a CD spectrum characteristic of an unfolded peptide(Figure 3.8).
This is in agreement with the notion that the transactivation domains are unfolded
before the interaction with their coactivator partners.
3.1.6 Isothermal Titration Calorimetry (ITC)
Characterization of affinity and stoichiometry for binding interaction between
biomolecules is a key area in analytical biochemistry[174]. Isothermal Titration
Calorimetry (ITC) is a method that uses the amount of heat released or absorbed
during a binding reaction (i.e. the binding enthalpy change) to measure the parameters
associated with binding[175]. Accuracy is one of the main advantages of ITC over
other general-use methods[175]. The strongest affinity that can be measured directly
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Figure 3.7: CD spectrum of the complex
Far UV CD spectra of the NCoA-1(257−370) with and without the peptide. The spectrum colored
black is of the complex and the red one is of the free form. The concentration of the NCoA-1
was 50 µM in 25 mM phosphate buffer, pH 6.5 and the complex was reconstituted in the CD
cuvette by adding an equimolar amount of the STAT6 peptide and spectra were measured after
a delay of 1 hour.
Figure 3.8: CD spectrum of the STAT6794−814
Far UV circular dichroism spectrum the the transactivation domain of the 21 amino acid STAT6
peptide, was measured with 25 mM concentration of the STAT6 peptide in 25 mM phosphate
buffer, 150 mM NaCl. Since there is no representative absorption at the usual range, it can
be presumed that the fragment containing amino acids 794-814 of the STAT6 transactivation
domain is unstructured.
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by ITC is in the nanomolar range[176].
Analysis of the results
Figure 3.9 shows results of the ITC experiment where NCoA-1(257−370) was incubated
with the concentration of the STAT6(794−814) peptide increased in incremental steps. The
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Figure 3.9: High sensitivity isothermal calorimetric titration of STAT6(794 − 814) peptide
with NCoA-1(257−420) in 50 mM HEPES buffer, pH 7.0, 150 mM NaCl and 1 mM DTT. The
concentration of the protein was 60 µM. The upper panel shows the power output in units of
µcal.s−1 as a function time for successive injections of the peptide. Eight microlitres of the
peptide was injected each time. The lower panel shows the binding isotherm corresponding
to the experiment shown in the upper panel. The enthalpy released per mole of the injectant
versus the molar ratio of the peptide (injectant) to protein was plotted. Using this plot, the
binding constant was calculated by making a fit using the non-linear least squares fit method.
results were analyzed using ORIGIN software provided by Microcal. The dissociation
constant (KD) calculated from isothermal calorimetry experiments was 0.8 ±0.4µ M.
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3.1.7 Fluorescence Spectroscopy
Electron Spray Ionization (ESI), analysis showed that the trials with peptides with
both N- and C- terminal cysteins failed to react with the dye. Next, the synthetic
carboxyfluorescein-tagged peptide was titrated into the NCoA-1(257−370) sample and the
emission spectrum at 480 nm was monitored using a spectrofluorimeter. The spectrum
turned out to be uninterpretable, possibly due to non-specific interaction of the tagged
peptide with the NCoA-1(257−370) fragment.
3.2 Results from NMR experiments
NMR studies of the NCoA-1257−420 fragment
The NCoA-1(257−420) fragment was concentrated up to 0.4 mM and a HSQC spectrum
was measured. This construct had the 10-Histidine tag attached to it. The spectrum
(Figure 3.10 (A)) was indicative of an unfolded protein or a protein arrested in the,
”molten globule state”, during its folding process. When the peptide was titrated
into this sample in a molar ratio of 1:1, the characteristic signature of an unfolded
or partially folded protein changed to that of a folded spectrum (Figure 3.10 B).
The HSQC spectrum of the NCoA-1(257−420) fragment without the histidine tag com-
plexed with STAT6(794−814) peptide in a 1:1 molar ratio, showed a number of poorly
dispersed N-H correlation peaks, which are rather sharp and indicative of amino acids
from the disordered region (Figures 3.11(a) and (b). Many other peaks were so broad
that they were hard to detect at all. A preliminary evaluation of the spectrum suggested
that about 60% of the NCoA-1(257−420) fragment had a defined structure. A series of
3D heteronuclear experiments (see Table 2.4 were measured to facilitate sequential
resonance assignment in the case of the NCoA-1(257−420) fragment in complex with
STAT6 peptide. Further analysis and resonance assignment trials indicated that the
region from the residue Leu371 in C- terminus onwards could be unstructured as
their resonances were very sharp in the 1H , 15N as well as the 13C
′
dimensions. Since
the rest of the residues showed very broad resonances assignment was very difficult.
Table 3.2 shows the number of residues in each of the three constructs studied by
NMR and their assignment details. Only fifteen amino acids could be assigned in
the case of NCoA-1(257−420) fragment and they were the peaks that had very sharp
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A B C
Figure 3.10: Comparison of HSQC spectra of the NCoA-1 (257-420) and NCoA-1 (257-
370) fragments
In the left is a HSQC spectrum of the NCoA-1(257−420) with the histidine tag (A), and the right
spectrum is of the NCoA-1(257−420) , when 1 molar equivalent of the STAT6 peptide was titrated
into the NMR sample tube(B). While the left HSQC is characteristic of an unfolded or partially
folded protein that resembles the spectrum of a ”molten globule”, e.g. ubiquitin in 8 M urea,
the right HSQC shows well dispersed peaks indicating that the protein starts folding once the
peptide was added. Spectra were measured in 50 mM phosphate buffer, pH 6.5, with 150 mM
NaCl. The lyophilized peptide was also taken in the same buffer at a stock conc. of 5 mM. (C) An
HSQC spectrum of the NCoA-1 (257-370) fragment free form. The spectra was measured at 600
Mhz, with a sweepwidth of 2500 Hz and 2400 Hz in the 15N and 1H dimensions respectively.
Number of scans = 4.
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Figure 3.11: A comparison of HSQC spectra of NCoA-1 (257-420) with and without
peptide
A comparison of HSQC spectra of the NCoA-1(257−420) with and without STAT6 peptide. The
NCoA-1(257−420) is without the Histidine tag in this case. The left spectrum which is of the
NCoA-1(257−420) with the STAT6 (794-814) peptide, and the one in the right is of NCoA-
1(257−420) without the peptide.
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lineshapes. From the assignment it was readily seen that they were from the C-
terminus. From this the conclusion is that the peaks in the extreme C- terminus
numbering about fifty are disordered, as all of them give rise to peaks characteristic
of the unfolded domain. Similar spectral quality was also found in the case of the
NCoA-1(257−385) , where comparison with the NCoA-1(257−370) HSQC spectrum showed
that the 15 amino acids from Lys371 could be in a disordered coil. Figure 3.12
shows the overlay of the NCoA-1(257−370) and the NCoA-1(257−385) HSQC spectra. This
is in agreement with the crystal structure of the complex, where residues after amino
acid 366 were not visible due to their unstructured and highly flexible nature. Only
the NCoA-1(257−370) construct showed a better quality spectrum amenable for three
dimensional heteronuclear experiments and subsequent resonance assignment. Nine
residues could not be assigned with the measured set of triple resonance spectra as they
had highly ambiguous resonances in the 13Cα dimension and lacked 13Cβ chemical shift
information. Figure 3.13 shows the HSQC peaks of the free NCoA-1(257−370) fragment
and the resonance assignments.
The nine ambiguous residues are as follows : 1. Thr277 2. Ser279 3. Asp290 4.
Lys291 5. Ile296 6. Phe299 7. Arg311 8. Leu313 9. Tyr348
It is notable that among these residues that could not be assigned only Ile296 has
close interaction with the STAT6 peptide.
Peak details NCoA-1(257−420) NCoA-1(257−385) NCoA-1(257−370)
No. of residues 164 139 114
Total no. of assignable
peaks
140 131 107
Peaks assigned by MARS - - 78
Peaks assigned manually 15 - 20
Ambiguous peaks - - -9
Table 3.2: Statistics of resonance assignment of the three NCoA-1 constructs
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Figure 3.12: An overlay of the HSQC of NCoA-1(257-370) over the HSQC spectrum of
NCoA-1 (257−385). The peaks in red with the assignment labels are of the 370 fragment
and those in green are from the 385 fragment. The sharp peaks in the spectrum of the
385 fragment are from the 15 amino acids that are to the extreme C- terminal.
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Chemical shift index (CSI) as a measure of secondary structure
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Figure 3.14: (a) Chemical shift index of the NCoA-1257−370 free form compared with a
secondary structure representation constructed out the PDB structure of the complex. CSI
values are plotted against the residue numbers as per the primary sequence. Positive values
indicate α helix while negative values indicate a β sheet. (b) The Isotropic 1J couplings in Hz
versus the residue number.
Figure 3.14(a) shows the CSI plot overlayed with the secondary structure cartoon of
the NCoA-1(257−370) in complex. Clearly, the change in the conformation in the second
β sheet (Bβ) sheet from the N- terminus can be seen. This also supported by the fact
that the residues involved in the interaction with STAT6(794−814) peptide like Ile272,
Ile275 and Ile277 are located in the strand Bβ. Significant change is also observed
in the Hβ strand in the C- terminus. Since the CSI values do not fall into a pattern
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suggestive of either α helix or β sheet, the nature of conformational change in the Hβ
strand cannot be explained. Both the longer constructs, the NCoA-1(257−385) and NCoA-
1(257−420) fragments could not be used for CSI studies because of the lack of sufficient
signals.
1JCαHα Isotropic couplings
There exists a relation between isotropic 1JCαHα couplings and the backbone φ and ψ
angles. These couplings are particularly useful for identifying residues with positive φ
angles. Residues with a positive φ angle have a 1JCαHα coupling 6 137 Hz. Figure
3.14(b) shows a plot of isotropic 1J Cα Hα couplings versus the residue number, com-
pared with the secondary structure pattern of NCoA-1(257−370) fragment. The residues
in helical regions have larger 1JCαHα values than others in extended regions. The two
main helices present in the crystal structure of the complex are clearly represented in
the plot of the free protein.
3.2.1 Titration of the peptide STAT6 (794−814)
into NCoA-1257−385
A HSQC spectrum of the NCoA-1(257−385) fragment showed peaks which were very weak
in intensity. An overlay of the HSQC spectrum of the NCoA-1(257−385) on that of the
NCoA-1(257−370) fragment showed that those peaks which were very sharp did not match
with the peaks from the NCoA-1(257−370) (See Figure 3.12). It could be concluded that
the peaks which were sharp arose out of the amino acids 271- 385 in the longer frag-
ment, and they were disordered. The peptide was added in increasing molar ratios with
respect to the protein as 0.2, 0.5, 1, and 1.5 times to the NCoA-1(257−385) concentrations.
Figure 3.15(a) shows the overlay of the region from the different titration steps, of the
peaks from the C- terminal region of the NCoA-1(257−385) fragment. The sharp peaks
that were possibly from the 15 amino acids towards the C- terminus did not show any
shifts from their position in the HSQC of the free form. In Figure 3.15(b), the peaks
within the circles are the peaks that did not move upon titration. This suggests the
possibility that the peaks are not affected by the addition of the STAT6 peptide.
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Figure 3.15: An overlay of HSQC spectra from different titration steps of the STAT6
peptide into the NCoA-1 (257-385) fragment. The peaks which have very sharp
lineshapes (encircled peaks in (b)) do not move upon titration with the peptide.
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3.2.2 Titration with the peptide STAT6 (794−814)
into NCoA-1257−370
The peptide ligand STAT6 (794-814) was titrated into to the NCoA-1 (257-370) in
increasing molar ratios of 1:1, 2:1, 3:1, and 4:1 and the sample was taken in a Shigemi
tube and a HSQC spectrum was measured using Bruker spectrometers of 600MHz and
700 MHz field strengths (Figure 3.16 (a) ). The shifting of the peaks was not uniform
Figure 3.16 (b). While the position of many of the peaks could be traced because their
location was not very far from that of the peaks from the free form, some other peaks
did not have any matching peak in the HSQC spectrum of the free form. Figure 3.17
shows the overlay of the HSQC spectra of the free form of NCoA-1(257-370) and the
complex of NCoA-1(257-370) with STAT6(794-814) where the ratio of NCoA-1 protein
to the STAT6 peptide is 1:4 Since the resonance assignment of the bound form was not
complete, chemical shift mapping of the entire NCoA-1(257−370) could not be represented
in a plot.
3.2.3 Studies of the free NCoA-1
Based on biological studies, the region between the amino acids 257-420 of the NCoA-
1/SRC protein was identified as the interaction partner of the STAT6 transactivation
domain. Limited proteolysis and gel Filtration experiments suggested that the region
of the NCoA/SRC protein comprising of the amino acids 257-370 was sufficient for the
interaction, although this construct did not crystallize on its own or in complex with
its STAT6 interaction peptide. Rather a slightly longer construct, the NCoA-1(257−385) in
complex with the STAT6 transactivation domain, crystallized. Crystallization trials with
the free NCoA-1(257−420) or the complex with STAT6 transactivation domain have not
been successful, so far. Circular dichroism spectra of the free and the bound form of
NCoA-1(257−370) and the NCoA-1(257−385) showed that there is no significant difference in
the overall secondary structure content between the two forms. But these spectra are
not indicative of the intrinsic conformational details. Since the crystallization of the
the free NCoA-1 LXXLL interaction domain was not possible, NMR was used to obtain
structural information.
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Figure 3.16: Overlay of titration steps of the NCoA-1 (257-370) at 700 MHz
Color codes for titration steps : 1. blue - free form ; 2. purple - 1 ; 3. green - 2; 4. red - 3 times
the molar ratio of the STAT6 peptide to the NCoA-1 (257-370) protein.
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Figure 3.17: An overly of the HSQC spectra of the free form of NCoA-1(257-370)
and the complex of NCoA-1(257-370) with STAT6(794-814) where the ratio of NCoA-1
protein to the STAT6 peptide is 1:4. Color code : red - free NCoA-1. blue - complex.
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3.2.4 NMR studies of the free NCoA-1
The studies on 15N and 13C labeled NCoA-1(257−420) fragment showed that the amino
acids 370-420 of the NCoA-1 constituted a highly flexible region. The studies on the
NCoA-1(257−385) fragment also showed that the amino acids 370-385 were disordered.
This is also the case in the crystal structure of the complex between NCoA-1(257−385) and
STAT6 peptide. Amino acids from Leu366 were not visible as they were unstructured.
The minimal domain identified through limited proteolysis, the NCoA-1(257−370) seems
to be ordered well as indicated by the NMR spectra. Ninety percent of the backbone
resonances amino acids could be assigned without ambiguity. Titration experiments
indicate that there could be a possible conformational change as the chemical shifts of
the residues with and without the peptide change in a non-uniform fashion.
3.3 Measurement of Residual Dipolar Couplings (RDCs)
3.3.1 Alignment of NCoA-1(257−370) Using Pf1 Phages
Different salt concentrations were used to test the alignment, and the protein concen-
tration was kept uniform. Precipitation occurred below salt concentrations of 150 mM.
The phage was pelleted out from the NMR sample by centrifuging at 45,000 r.p.m.
for 1 hour, using a Beckman Coulter L80 ultracentrifuge. The pelleted phage had a
whitish appearance. The supernatant was checked for protein at 280 nm UV absorption
and the protein content was reduced to half the initial concentration. The spectrum
was measured in a Bruker Avance 800 MHz spectrometer and the D2O splitting of 8
Hz was found at a salt concentration of 600 mM using a 13C,15N labeled sample.
The D2O splitting gave an estimate of the concentration of the phage particles in
the NMR sample. 15N /13C labeled NCoA-1(257−370) with a concentration 0.3 mM in
50 mM PO4 buffer, pH 6.5 and 600 mM NaCl was aligned with 10 mg/ml phages
(Profos Biolabs, Munich), and an IPAP HSQC type experiment was recorded to obtain
N-H J+D couplings. The data were processed with NMRPipe[177] software from NIH
and accessory scripts were used to calculate the couplings. Figure 3.18(a) shows a
representative doublets from protein samples aligned using Pf1 phages. It is an overlay
of the in-phase and anti-phase components from an IPAP-HSQC. Pf1 was added at a final
concentration of 4mg/ml. The anti-phase component is not of the same intensity as the
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in-phase component because of line-broadening. The reason for the line-broadening
could be excessive alignment. Figure 3.18(b) shows the splitting of Thr366 in (1)
2mg/ml phage and (2) 5 mg/ml phage, which is 91 Hz and 93 Hz respectively.
The increase in phage concentration did not increase the alignment further, but line-
broadening was observed. One possible explanation for this behaviour of the protein is
that a part of the protein interacts with the phages and aggregates, thus destroying the
nematic phase, while the remaining protein aligns excessively with the phage particles
that remained in solution.
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Figure 3.18: (a) Overlay of the inphase and antiphase components of an IPAP
spectrum. (b) Splitting of Thr366 peak in Pf1 phage medium
(a)The peak in red shows the anti-phase component of the IPAP while the peak in blue is the
in-phase component. Both spectra were measured in an interleaved manner and processed
separately by extracting them. The above figure shows the overlay of the in-phase and anti-
phase component of the signal from a representative residue. The anti-phase peak is not of
the same intensity as of the in-phase peak because of the line-broadening. (b) J NH + D NH
splitting of the amide residue Thr336 at (1). ¿ 2 (2) 5 mg/ml Pf1.
3.3.2 Measurement of Residual Dipolar Couplings
Since there was a huge line broadening effect that hindered the use of HNCO-TROSY
type experiment for the measurement of dipolar couplings, perhaps due to a much
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faster relaxation due to the interaction between the protein molecule and the bicelles.
An IPAP type experiment was used to obtain NH dipolar couplings using a Bruker 600
MHz spectrometer, equipped with a cryoprobe. The quality of the spectrum was very
poor with extremely broad peaks. It was not possible to get any couplings, from this
trial. Addition of a positively charged lipid molecule like CTAB up to 5mMwas expected
to reduce the interaction between the protein and the biomolecule but did not improve
the situation.
3.3.3 Polyethylene glycol based medium (Otting phase)
Precipitation was observed. This sample was used to check the quadrupolar splitting
of deuterium using a Bruker 400 MHz spectrometer. Neither the D2O splitting nor the
protein signal was observable.
3.3.4 Polyacrylamide gels in alignment
A HSQC spectrum of NCoA-1(257−370) in 7 % was measured, which showed peaks only
from the side chain region. Figure 3.19 shows the HSQC spectrum. The reason could
be that during the diffusion of the protein sample inside the gel, most of the protein
sample would have aggregated.
Paramagnetic Tags
The two cysteins present in the NCoA-1(257−370) fragment, Cys295 and Cys365 were
suitable for the attachment of the tag. MALDI spectroscopy showed an increase of
molecular weight but the increased weight did not correspond to an attachment of the
tag whose molecular weight was 527 Da, either with one of the cysteins or with both.
Table 3.3 shows the expected and observed molecular weights. The sample used for
the trial was double labeled. The expected molecular weight is for a doubly labeled
sample.
Different concentrations of phages and NaCl were used for alignment. When a
phage concentration of 2 mg/ml was used 37 N-H RDCs could be obtained from an
IPAP spectrum. Tables 3.4 and 3.5 show the details of the various trials done using Pf1
phages as alignment medium. Results from other alignment media are listed in Table
3.6.
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Figure 3.19: HSQC showing the NCoA-1257−370 aligned in 7 %polyacrylamide gel. The
concentration of the protein was 0.4 mM, with 15% D2O. The spectrum was recorded using
a Bruker 900 MHz spectrometer attached with a cryoprobe and spectral widths in the F1 and
F2 dimensions were 2730 Hz and 4323.3 Hz, respectively. The number of t1 increments = 64.
Table 3.7 shows the parameters important in the analysis of the N-H dipolar
couplings. Analysis of the couplings was done by using PALES[178] software. A
correlation of the experimental dipolar couplings was done against the back-calculated
dipolar couplings from the PDB file of the crystal structure of the complex of the NCoA-
1(257−370) with STAT6 peptide.
The Qsaupe was calculated according to a previous work[146]. A correlation of 0.480
is not valid from a structural point of view.
RDCs were predicted from the crystal structure of the complex between
STAT6(794−814) peptide (minimal transactivation domain of STAT6) and the NCoA-
1(257−385) fragment. Measured RDCs were from the free form of the NCoA-1(257−370) .
The absolute value of the magnitude of the alignment tensor (Da) obtained was
1.15×104 Hz. This value is too small that it falls within the root-mean-square
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Molecule Expected molecular
weight
Mol. Weight from MALDI
in Daltons
Free NCoA-1(257-370) 13528.22 13825
(control)
NCoA-1(257-370) + 3
times molar
14562.22 15153
excess paramagnetic tag
Table 3.3: Calculated and experimental molecular weights for the NCoA-1(257−370)
unreacted and reacted with the paramagnetic tag
Expt. 2mg/ml 3.5 mg/ml 4 mg/ml 5 mg/ml
D2O splitting - - - -
IPAP no. of couplings ∼ 50 6 10 6 10 6 10
Salt titration - - -
HNCO-TROSY - - 37 couplings -
Other 2D expts - - - -
Table 3.4: Different concentrations of phages and their effect on alignment.(1)
The sample is unstable and aggregates in a few days, after the addition of phages.
uncertainty of the alignment tensor. This indicated that the average size of the dipolar
couplings obtained is within the error range and therefore the correlation of 0.48
obtained using alignment with Pf1 phages is not structurally valid[178].
In another trial, the couplings were chosen from those regions where the secondary
structure elements as indicated by the CSI plot do not show any change when compared
to the predicted secondary structure from the crystal structure of the complex. In Figure
3.20, the correlation plot of predicted and experimental dipolar couplings is shown.
There is no correlation between the measured and predicted RDCs as seen from the
plot. This could mean that the total set of N-H RDCs obtained experimentally are not
useful for comparison of the predicted RDCs from the crystal structure of the complex
and the measured RDCs from the free NCoA-1(257−370) fragment. It is also possible that
the structure of the free form differs drastically from the complex, but this not seen
in the CSI plot, where marked changes are seen only in the Bβ and Hβ strands of the
complex. While there is a helical tendency in the former strand whereas the changes
are not explainable in the latter strand.
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Expt. 8mg/ml 10 mg/ml 16 mg/ml 20 mg/ml
D2O splitting 7.9Hz 10 Hz, aggregation - -
IPAP - - - -
Salt titration 5 steps 1 step 1 step 1 step
HNCO-TROSY - - - -
Other 2D expts HNCO-ECOSY - - -
Table 3.5: Different concentrations of phages and their effect on alignment. All the
experiments were performed in the same buffer condition, that is, 50 mM PO4, 150
mM NaCl, pH 6.5, 1 mM DTT. The sample is unstable and aggregates in a few days,
after the addition of phages.1. Except for the 8mgs/ml experiment, all other conditions
were tried using unlabeled sample.2. The D2O splitting was not observable in higher
concentrations, the reasons are unclear.
Alignment medium D2O splitting IPAP
DHPC:DMPC bicelle 7 Hz -
DHPC:DMPC bicelle + 5 mM CTAB 7 Hz 20 couplings
Polyacrylamide gel ( 7 %) 10 Hz -
C12E5/hexanol - -
Paramagnetic tag wrong mol. wt. -
3% agarose - -
Table 3.6: Other alignment trials
Since the NCoA-1 is a highly basic protein, it is positively charged at a lower pH.
Moreover, from the crystal structure it is evident that the peptide sits in a largely
hydrophobic groove, which could possibly be exposed to water, in the absence of
the peptide. Since the NMR measurement conditions require a pH of below 7.0, the
protein is positively charged in the case of NMR buffer. As the Pf1 phages have a
negative charge of -5 units, there is a very strong electrostatic interaction between
the NCoA-1 and the phages at the pH of 6.5. Therefore there is too much alignment
and consequently there are very broad NMR peaks. Therefore it was not possible to
obtain dipolar couplings that are suitable for structural analysis. Three dimensional
structure calculation using NOESY spectrum requires side chain resonance assignments.
This is time consuming and prone to ambiguity. Given the availability of a crystal
structure, measurement of dipolar couplings was considered as an easier alternative to
get structural information. The nature of the free form of NCoA-1 did not allow it to be
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Parameter value
No. of couplings 39
RMS 3.028
Chi2 index 357.468
Correlation coefficient 0.480
Qsaupe 0.951
Da -1.158391e-04
Da−NH -2.500
Table 3.7: Dipolar coupling analysis using PALES software
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Figure 3.20: Correlation between experimental 1DNH values. Only those couplings
from the residues that are in the regions where secondary structure elements predicted
from the crystal structure and CSI values of the free NCoA-1(257−370) fragment are
similar were used for correlation. A total of 33 dipolar couplings were used.
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appropriately1 aligned either sterically or electrostatically in existing alignment media
commonly used for aligning proteins. Hence, it was not possible to obtain suitable2
dipolar couplings that would give structural information in three dimensions.
1The alignment was either too strong, or there was no alignment because of protein precipitation.
2The number of couplings were not enough, and the magnitude of the couplings were small.

Chapter 4
Discussion
The NCoA-1(257−385) fragment and STAT6(794−814) eluted together in gel filtration trials
indicating that the binding affinity of the peptide to the protein was very high. This
was proved by the fact that MALDI (Matrix Assisted Laser Desorption and Ionization)
experiments on the trypsin digested NCoA-1 fragments showed that the mass of the
most stable fragment (14,795 Da.) corresponded to a fragment comprising of amino
acids 257-385 of the NCoA-1 protein. N- terminal sequencing of the fragment by Edman
degradation also confirmed the identities of the protein and the STAT6 transactivation
domain. Secondary structure prediction showed that amino acids C- terminal to
residue 366, in the NCoA-1(257−420) , were disordered. Based on the limited proteolysis
and secondary structure prediction two smaller constructs, the NCoA-1(257−385) and
NCoA-1(257−370) were cloned. Crystallization screens were set up for these two shorter
domains, in addition to theNCoA-1(257−420) fragment, by Ms. Karin Giller and Dr. Stefan
Becker. All the three domains were used for the screening, each of the domains were
in complex with STAT6(794−814) peptide, as well as in free form. One of the samples, the
complex between STAT6(794−814) peptide and theNCoA-1(257−385) fragment crystallized.
The structure was solved by Dr. Adelia Razeto and Dr. Stefan Becker, and the details of
crystallization and structure elucidation have been published[179, 180].
The crystal structure revealed that the NCoA-1 (259−367) fragment in complex with
STAT6794−814 shows a PAS domain. PAS domains were first found in eukaryotes,
and were named after homology to the Drosophila period protein (PER),the aryl
hydrocarbon receptor nuclear translocator protein(ARNT) and the Drosophila single
minded protein (SIM). PAS domains are located in the cytoplasm and are commonly
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found in serine/threonine kinases [181], histidine kinases [182], photoreceptors and
chemoreceptors [183], cyclic nucleotide phosphodiesterases [184], circadian clock
proteins [185], voltage-activated ion channels [186], regulators of responses to hypoxia
[187] and embryological development of the central nervous system [188].
The structure of the NCoA-1 PAS-B domain in complex with the STAT6 peptide now
adds a new fold to this family of φχχφφ motif interacting domains. This nomenclature
(PAS-B) was chosen as there is a another predicted PAS domain upstream, in the
NCoA-1 molecule[90]. It extends the number of signal transduction modules, whose
structures have been solved in complex with protein fragments containing unmodified
signature motifs. Figures 4.6 and 4.1 shows the diagrammatic representations of the
NCoA-1(257−385) and Photo active Yellow Protein (PYP) PAS folds respectively. It shows
that NCoA-1 in complex with STAT6 transactivation domain adapts a canonical PAS
domain.
The PAS domain of NCoA-1 consists of a five-stranded anti-parallel β-sheet from Aβ
to Hβ and three α helices, Cα to Eα, which connect the second and third β strands, Bβ
and Fβ (Figure 4.6). The STAT6 peptide binds between the helix Dα and strand Bβ of
the NCoA-1 PAS-B domain. In the STAT6(794−814) peptide, residues 799-807 form a two
and a half turns α-helix, while residues 795-798 are in an extended conformation. The
STAT6 helical axis is tilted both with respect to the axis of the Dα helix and to the Bβ
strand by an angle of approximately 50◦(Figures 4.1 (a) and (b)).
Figures 4.2(a) and 4.2(b) show a comparison of the NCoA-1 PAS-B domain and the
PAS domain of the Photoactive Yellow Protein(PYP) which has a similar basic topology.
PYP is a bacterial light sensing protein, and together with the HERG (human ether-
a-gogo-related gene) voltage-dependent K+ channel, shares structural similarity with
the NCoA-1 PAS-B domain according to the program DALI[189]. The whole structures
of the PYP and HERG PAS domains when individually superimposed over the NCoA-1
PAS-B domain, have r.m.s.d. values of 3.0 A˚ and 2.7 A˚ respectively.
4.0.5 Interaction of the STAT6 peptide with the NCoA-1 PAS-B Do-
main
The electron density of the structured STAT6 peptide allows detailed analysis of in-
teractions with the NCoA-1 PAS-B domain. The peptide is attached to binding cleft
of the PAS-B domain, asymmetrically(Figure 4.1(a)). It is tightly packed against the
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Figure 4.1: View of the STAT6/NCoA-1 PAS-B complex in mutually orthogonal orientations.
The β sheet is depicted in dark blue and the α helix is shown in light blue. The STAT6 peptide
is shown in red.
rim containing the Arg293 anchor (Figure 4.3a). Due to this positioning, no ordered
water molecules are found in this rim and the peptide. There is a relatively large
space between the STAT6 peptide and the opposite rim. This space is occupied by
a network of ordered water molecules, which mediate indirect interactions with the
residues of the PAS-B domain. The STAT6 peptide binds into a shallow groove at the
surface of the NCoA-1 PAS-B domain. The groove is about 20A˚ in length and 10 A˚
in width as estimated from Cα distances. Hydrophobic residues seal the floor of the
groove (Ile272, Ile273, Ile275 on the Bβ strand, the methyl group of Thr277 on the
Cα helix, Trp288, Val292, Ile296 and Phe300 on the Dα helix) forming a, ”hydrophobic
pocket”, while the hydrophilic side-chains lining the walls of the groove, are directed
outwards into the solvent region. The STAT6/NCoA-1 PAS-B domain interface buries
865 A˚2. The STAT6 peptide is amphipathic, presenting hydrophobic residues at the
NCoA-1 interface and polar or hydrophilic residues on the solvent side(Figure 4.4).
The Leu-sidechains of the STAT6 LXXLL signature motif are deeply embedded into the
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hydrophobic floor of the PAS-B domain. The side chains of the Leu’802 andLeu’805
have the least accessible surface within the peptide, 6 A˚2 and 20 A˚2, respectively. Their
substitution by alanine abolished binding to NCoA-1 in vitro, recruitment of NCoA-1
and consequently in its transactivation potential in cells[97]. Therefore not only the
hydrophobicity of the motif, but also the size of the side-chains is essential for binding
to the NCoA-1 PAS-B domain.This is clearly explicable by the crystal structure: the
molecular surface of the peptide, at the signature motif, is complementary with the
groove in the PAS domain(Figure 4.5).
Leu’802 fits perfectly into a deep pocket within the hydrophobic groove: it estab-
lishes Van der-Waals interactions with Ile275 and Ile296. Leu’805 fits into shallow
pocket formed by Ile272 and Ile275 side chains and by Cα of Ile273 and Ser274. Leu’806
fits deep into deep pocket formed by the methyl group of Thr277 and the side-chains
of Ile275 and Trp288. However Leu’806 is more accessible (38A˚2) than Leu’805 and
Leu’802, because from one side it is not shielded from the solvent.
Pro’796 and Pro’797 in the extended N-terminal part of the STAT6 peptide pack in
a shallow depression formed by Phe300 and Ile296 at the C-terminal end of the PAS-B
domain Dα helix. The STAT6 peptide is anchored by the Arg293 side-chain through
hydrogen bonds with the hydroxyl group of Thr’803 and the backbone carbonyl of
Glu’799. This anchor is strengthened by a weak salt bridge (3.17 A˚)between the side-
chains of Arg293 and Glu’799 (Figure4.4b). The hydrogen bond to the Glu’799 carbonyl
is the only direct contact of a PAS residue to the backbone of the STAT6 peptide.
All other contacts between STAT6 and the PAS domain are side-chain to side-chain
interactions (See Figures 4.3(a) and 4.3(b)). Therefore the peptide does not sit deep
in the binding cleft, but is rather kept at a distance (Figures 4.3 and 4.3). The spacing
between Leu’802 and Leu’805 is necessary to position these two residues and Leu’806
in their respective pockets and only one orientation of the peptide in the groove is
allowed.
A chargeclamp (hydrophilic clamp) is not found in the complex of the STAT6 peptide
is not found in the complex of the STAT6 peptide with the NCoA-1 PAS-B domain.
The side-chain of the Arg293 forms two hydrogen bonds and a salt bridge with the
STAT6 peptide (Figure 4.4a and 4.4b). Due to the absence of such a chargeclamp,
hydrophobic interactions play a central role in positioning the STAT6 fragment in the
NCoA-1 PAS-B domain binding groove. Therefore the STAT6 fragment bound to the
NCoA-1 PAS-B domain is the first activator/coactivator complex so far studied where
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(a)
(b)
Figure 4.2: Superposition of the STAT6/NCoA-1 PAS B complex and the HERG PAS domain.
The HERG domain is depicted in yellow, the STAT6 peptide is shown in red and the NCoA-1
PAS-B domain in light blue. For clarity the model of the STAT6 peptide in (a) and the model of
the NCoA-1 PAS-B domain in (b) have been omitted.
the surface complementarity between the hydrophobic faces almost exclusively defines
the orientation of the two proteins relative to each other.
Inspite of extensive research, the molecular basis of transactivation is poorly under-
stood. One of the reasons is that there is little sequence similarity among transactivation
domains. They generally have a poor intrinsic propensity to form secondary structure,
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(a)
(b)
Figure 4.3: (a) Surface representation of the NCoA-1 PAS-B domain. Color code for the
residues : acidic - red ; basic - blue; aliphatic - yellow; aromatic - green ; hydrophilic - cyan. (b)
The complex is rotated by 90◦ about the horizontal axis of (b).
(a) (b)
Figure 4.4: Close views of the interaction between the STAT6 peptide and the NCoA-1 PAS-
B domain. (a) View along the helical axis of the STAT6 peptide. The residues of the STAT6
peptide involved in interactions are colored grey. Their partner residues in the NCoA-1 PAS-B
domain are colored blue. Dotted lines indicate hydrophilic and electrostatic interactions. (b)
Perpendicular view of the interface in an orientation rotated 90◦ about the vertical axis of (a).
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Figure 4.5: A cross section of the interface showing the complementarity of the STAT6 peptide
with the PAS-B domain groove. The NCoA-1 PAS-B domain surface is represented as a wire
mesh and the STAT6 peptide is in filling representation.
although they need to make specific interactions with several different target factors.
This confirms the notion that minimal requirement for partner recognition is defined
by very short stretches of amino acids, which become structured only when bound
to target proteins. In the structure of the NCoA-1-PAS B domain complex with the
STAT6(794-814) peptide the ordered part of the peptide (795-807) constitutes such a
minimal structural entity. The LXXLL motif has been described before as a module
mediating the interaction of the p160/SRC/NCoA cofactors with nuclear hormone
receptors(NRs)[94]. In addition all the SRC/NCoA coactivators contain LXXLL mo-
tifs within a domain that mediates complex formation with the CBP, called the CBP
Interacting Domain (CID).
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There are a few cases where three dimensional structures of transactivation domains
in complex with their coactivators have been solved. Those structures show a similar
mechanism of transactivation as the STAT6 transactivation domain. The nuclear factor
CREB activates transcription of target genes in part through direct interactions with
the KIX domain of the coactivator CBP in a phosphorylation-dependent manner[190].
The solution structure of the complex formed by the phosphorylated kinase-inducible
domain (pKID) of CREB with KIX reveals that pKID undergoes a coil to helix folding
transition upon binding to KIX domain, forming two alpha helices. The amphipathic
helix αB of pKID interacts with a hydrophobic groove defined by helices α1 and α3 of
KIX. The other KID helix, αA, contacts a different face of the α3 helix. The phosphate
group of the crucial phosphoserine residue of pKID is hydrogen bonded to the side
chain of Tyr-658 of KIX. The structure provides a model for interactions between other
transactivation domains and their targets. The structure of this complex shows that
activating regions do fold and become ordered. Though KID is disordered in the free
state, it folds into a helix upon binding to the KIX domain of the CBP. This adds to the
previous notion that no specific structure is required for the recruitment process[191].
When the αA helix of the KID was destablilized, with mutations, the complex formation
with the KIX domain of the CBP was disrupted, suggesting a role for the secondary
structure in transcriptional activation[192]. NMR and biochemical evidence suggest
that the minimal acidic domain of the herpes simplex virus VP16 undergoes an induced
transition from a random coiled state to an α helix upon binding to its target protein
human TFIID TATA box-binding protein associated factor[193]. This work attempted to
tackle the question of the role of acidic residues in transactivation. The results from
this work show that hydrophobic residues of the transactivation domains also play
an important role. The Murine Double Minute 2 (MDM2) oncoprotein is a cellular
inhibitor of the p53 tumor suppressor. It can bind the transactivation domain of p53
and down regulate its ability to activate transcription. The crystal structure of the
109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation
domain peptide of p53 reveals a deep hydrophobic cleft in the MDM2 on which the
p53 peptide binds as an amphipathic α helix[194]. The interface relies on the steric
complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix
and, in particular, on a triad of p53 amino acids–Phe19, Trp23, and Leu26–which
insert deep into the MDM2 cleft[194]. These same residues of p53 are also involved in
transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its
95
transactivation domain. The structure also suggests that the amphipathic alpha helix
may be a common structural motif in the binding of a diverse family of transactivation
factors to the TATA-binding protein-associated factors.
4.0.6 The PAS domain is a new interaction module for LXXLL motif
While the LXXLL and similar motifs form structurally homologous amphipathic helices,
their target proteins share no structural similarity. The binding grooves of the NR AF2
domain, the CBP KIX domain, the CBP glutamine rich domain and the NH2- terminal
MDM2 domain are mostly made of different helical folds. The structure of the NCoA-
1 PAS-B is a new fold in the existing family of φχχφφ motif interacting domains.
It extends the number of signal transduction modules, whose structures have been
solved in complex with protein fragments containing unmodified signature motifs. The
importance of PAS domain in the NCoA/SRC activator function is not clear. A possible
role in the formation of coactivator multiprotein complex has been suggested. Several
three dimensional structures of eukaryotic proteins have already been solved. The
crystal structure of NCoA-1/STAT6 complex is the first structure where detailed insight
into the interaction of a PAS domain with its ligand is available. This forms the basis
for studying this domain of NCoA-1 with other interaction partners and in general, the
interaction of other PAS domains with their protein or peptide ligands.
4.0.7 The binding specificity between NCoA-1 and STAT6
NCoA-1 and not the proteins related to same family, NCoA-2 and NCoA-3, interact with
STAT6[84]. To confirm that the binding specificity depends on the PAS-B domain, the
interactions of the in vitro translated homologous PAS-B regions from the three NCoA
isoforms, with the STAT6 transactivation domain were investigated in a GST pulldown
experiment[97]. As expected, the NCoA-1 PAS-B domain strongly interacted with the
GST fusion protein comprising of the residues 677-847 of the STAT6 transactivation
domain.
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4.0.8 Determinants of Binding Specificity
A sequence alignment of residues 259-367 of the NCoA-1-PAS B domain with the
homologous sequences 267-376 of NCoA-2 and 262-370 of NCoA3 demonstrates, that
those residues making specific-side chain contacts to the STAT6 peptide, are all well
conserved or highly homologous between the three PAS domain sequences. Based
on the available structure of the STAT6/NCoA-1 PAS-B complex we cannot identify
individual residues in the NCoA-1 PAS-B domain, which cause specific binding to the
STAT6 LXXLL motif. The inability of NCoA-2 and NCoA-3 to bind to STAT6, despite of
the high sequence conservation in their PAS regions, strongly suggests that surface
complementarity plays an essential role not only for the orientation of the STAT6
peptide in the NCoA-1 binding groove, but also for binding specificity. A dissociation
constant in the order of 10−1 micromoles shows that the strong affinity for the STAT6
transactivation domain in vitro, under near physiological conditions shows that that
PAS domains are able to function as interaction domains in intracellular signaling. The
KD value is also in accordance with the values found for intracellular protein-protein
interactions. It was also clear from isothermal calorimetry that the interaction between
NCoA-1 PAS-B domain is exothermic, and hence there is no additional energy needed
for this particular step of signaling.
4.1 PAS domain
The first 3D structure of a PAS domain determined was the structure of the Ectoth-
iorhodospira halophila blue-light photo receptor PYP (Photoactive Yellow Protein). PYP
undergoes a self contained light cycle. Light-induced trans-to-cis isomerization of the
4-hydroxy-cinnamic acid chromophore and coupled protein rearrangements produce
a new set of active hydrogen bonds. Resulting changes in shape, hydrogen bonding
and electrostatic potential at the surface form a likely basis for signal transduction
[195]. In the years after, a number of PAS domains have been determined. These
include the 3D structure of the heme-binding domain of the rhizobial oxygen sensor
FixL, from Bradyrhizobium japonicum [196] and from Rhyzobium meliloti [197]. The
structural resemblance of the FixL heme domain to the PYP indicates the existence of a
PAS structural motif, although both proteins are functionally different. The N-terminal
domain of the human ether-a-go-go-related potassium channel, HERG which is the
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first 3D model of a eukaryotic PAS domain [198], the FMN containing phototropin
module of the chimeric fern Adiantum photoreceptor [199], and the solution structure
of the N-terminal PAS domain of human PAS kinase [200], and the PAS like domains,
periplasmic ligand binding domain of the sensor kinase, CitA [201] and the sensory
domain of the two component fumarate sensor, DcuS [202] have seen solved. The
beta-sheet of all the eight structures superimpose well [203].
Ponting and Aravind (1997) have proposed that the PAS sequence can be split into
two separate regions, the PAS domain and the PAC motif. Although the PAC motif is
proposed to contribute to the PAS domain structure, many PAS sequences in the SMART
and the PFAM databases are not linked to a PAC motif, which raises a possibility of the
existence of differences in the PAS domain superfamily. In the PFAM database there
are sequences of almost of 1000 PAS domains representative of all kingdoms of life.
Structural analysis of PAS domains in the PDB demonstrates that the PAS and PAC
motifs split the five-stranded β-sheet into two sections. In the large scale modeling
presented by [203], the PAS and PAC motifs are inseparable and together give rise to a
structural fold.
The PAS fold represents an important sensory domain present in all kingdoms of life,
and in the PFAM database many proteins appear to have more than one PAS domain.
It is therefore possible that such proteins may utilize cofactors in multiple PAS domains
to integrate different environmental signals. It has been shown that certain artificial
chemicals can specifically bind into the well packed hydrophobic core of a PAS domain
from PAS kinase [200], producing significant conformational changes therein. Studies
of two PAS domains with natural cofactors, AsLOV and photoactive yellow protein, have
shown that relatively small changes in these internally bound compounds are sufficient
to displace α-helices bound onto the same β-sheet interface [204].
One class of PAS domains is the light-oxygen-volta-ge LOV domains which bind
to flavin chromophores. Biophysical studies to define this pathway have produced
conflicting data, because crystallographic studies of LOV domains show minimal light-
induced conformational changes, whereas spectroscopic data suggest more pronounced
structural rearrangements occur upon illumination. These conflicts were resolved
by NMR spectroscopy, where it was shown that structural elements outside of a
PAS domain core undergo light-induced conformational changes and thus provide a
pathway for propagating structural changes to the kinase domain.
Among all the structurally characterized interactions of PAS domains with their
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(a)
(b)
Figure 4.6: (a)The PAS fold the the NCoA-1. (b) Pictorial representation of the
(Photoactive yellow protein domain (PYP)
ligands, the PAS domain complex of NCoA-1 and STAT6 transactivation domain is
the first PAS domain to be solved along with a peptide ligand. Although the crystal
structure of NCoA-1 PAS-B domain in complex with the STAT6 peptide, provides some
detailed insight into the mechanism of transactivation by the recruitment of cofactors, it
does not reveal the conformational changes in the cofactor that facilitate the specificity
of this interaction. Therefore the results from the NMR studies of the free form are
particularly important. Although PAS domains share a common fold, they have little
sequence homology, except for a few residues which are conserved[205]. Most of these
residues are located in the helix αA, which appears to act as a lid on the ligand binding
pocket and undergoes conformational changes[195]. In the case of the free form of
NCoA-1 however, as shown by the chemical shift index calculation, the conformational
change is likely to be in the first β sheet. As shown by the titration studies, while
majority of the residues do not undergo a major rearrangement, some of the residues
do show significant changes in their location in two dimensional spectra. It is likely that
the free form the amino acids from Lys271 to Lys280 constitute an α helix whereas in the
complex they undergo a conformational change to form a part of the β sheet. This is in
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confirmation with the previous studies on PAS domains where the αA/B segment moves
in concert, and they all share not only a common structural motif but also a similar
way of conformational flexibility. This evolution could have possibly have facilitated to
accommodate the various input signals from different ligands and cofactors located at
different positions in the domain and to transmit the signaling event to downstream
transducer proteins.
4.2 Structural information from NMR
In order to calculate the three dimensional structure of proteins, structural constraints
from Nuclear Overhauser Effect (NOE) alone or additionally Residual Dipolar Couplings
(RDCs) should be obtained. NOEs are dependent on the distance and are short range
interactions. Since fold determining constraints come from side chain contacts in the
hydrophobic core of the proteins, side chain resonance assignments are a prerequisite
for calculation of protein structures using NOEs alone. But the experiments that
would facilitate the assignment of side chain resonances are relatively insensitive when
compared to those used for backbone resonance assignments. Assignment of side chain
resonances and NOE identification are time consuming. Measurement of RDCs was
considered as an option for the assessment of the backbone structure of the free form
of NCoA-1. However, use of RDCs alone for backbone structure elucidation is not
without problems. The inherent ambiguity present in RDCs with respect to orientation,
entails that additional alignment tensors are required to resolve the equivocacy of
vectorial information. Since the alignment tensors are also dependent on the nature
of the liquid crystal used for alignment, more such tensors can be obtained by using
different alignment media. In the case of involvement of electrostatic attraction
between the solute molecules and the medium as in the case of Pf1 phages, varying
degrees of alignment and hence the corresponding tensors can be obtained simply by
changing the ionic strength of the buffer used. Measurement of RDCs for NCoA-1 in
various alignment media were marred by many factors like precipitation of the protein,
unfavorable line broadening impeding with accurate estimation of dipolar couplings,
and lack of signal. The reasons are manifold.
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Some proteins exhibit extreme line broadening at Pf1 phage concentrations (20-50
ml/L) used to align acidic biomolecules, which would appear to limit the general appli-
cability of such a technique[206]. Ojennus et al.,[207] reported that a Src homology do-
main, when aligned with an anomalously low concentration of the Pf1 phage, exhibited
a low affinity binding mechanism that leads to an enhanced alignment. They showed
that, at 2 mg/ml an optimum degree of alignment was achieved. Nitrogen linewidths
are broadened approximately twofold at this concentration and higher concentrations
of phage result in a prohibitively large line broadening. At this low concentration
of phages required to obtain optimum alignment, modest line broadening does not
interfere with the accurate measurement of large dipolar couplings. This effect was
more pronounced in the case of the NCoA-1 domain, where large linewidths led to a
spectrum of poor quality, making the evaluation of dipolar couplings difficult. Pf1 is
negatively charged at pH 7.4, with an approximate linear charge density of 10 e/nm,
and has a molecular weight 3.75 × 107 g/ml [208]. NCoA-1() is a highly basic protein
with a pI of 9.6 and positively charged at pH 6.5. There could possibly be a high
electrostatic interaction between the NCoA-1 and the Pf1 phages. The subunits of the
Pf1 coat protein are connected to each other by extensive hydrophobic interactions. The
exterior of the phages is composed of an elaborate array of N- terminal double hooks,
made of six amino acids, Gly1 to Ser6[209]. It is probable that the hydrophobic groove
of the NCoA-1 interacts with the exterior of the Pf1 phages which could possibly explain
the irreversibility of the line broadening upon increasing ionic strength. Lowering the
phage concentration to 1-2 mg/ml reduces the degree of induced order, but need not
solve the line broadening problem [207]. Addition of salt increases the hydrophobicity
of the protein, thereby facilitating other non-ionic interactions with the phage particles.
Broadening also occurs when nucleic acids, apocalmodulin, and thioredoxin are aligned
with phages [206]. But there is no significant change in the T 1ρ and T2 relaxation
time constants[206]. The observed line broadening could be attributed to presence
of additional 1H -1H dipolar couplings rather than a change in the correlation time.
Filamentous phage are highly acidic[208] with a pI of 4.0. This could also possibly be
the reason for a very high attraction exhibited by the NCoA-1 to the phage particles.
Since the quality of the 15N edited T 1ρ spectra of the NCoA-1(257−370) aligned in Pf1
phages were also very poor with no well resolved and dispersed peaks it was not
possible to estimate relaxation times for the protein aligned with the phages.
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In the case of bicelles, the poor quality of the spectra could be attributed to the
destructive effect of the salt concentration on the stability of bicelles. Since bicelles
are unstable over a period of time usually a few days to a week, typical time length
used for multidimensional NMR experiments, the combined effect of the high salt
and commercial impurities lead to hydrolysis of the phospholipids making the whole
environment hydrophobic[157]. The NCoA-1 protein is free to interact through its
hydrophobic patch with the hydrolysed lipids, leading to instability of samples. It is not
known, however, the reason for the inefficiency of CTAB to stabilize the sample. There
is always a hydration term as well as the repulsive part of the Van der Waals interaction
that keeps the bilayers from collapsing. But, a secondary minimum can arise at longer
distances under certain combinations of electrostatic and Van der Waals terms. As
the electrostatic term is modulated by ionic strength, these minima occur only above a
certain salt concentration. It is these minima that are responsible for micelle and bilayer
aggregation. For this to occur, the bilayer or micelle should be inherently charged,
before this ionic strength dependent phenomenon happens. However, in the absence of
weak charge there can be minima which result from the interplay of hydration and
Van der Waals forces that also lead to aggregation. It is known that neutral lipid
bilayers have an inherent tendency to aggregate in multilayer particles. The effects
of ionic strength on what appears to be bicelle aggregation appears to be reminiscent
of those on the aggregation of other bilayer and micelle systems [210]. There are two
major forces that act between surfaces of lipids and influence interactions, such as the
aggregation of bilayers. Van der Waal’s forces occur between all solute molecules in
water. At long distances, these forces are attractive [211]. If the interacting surfaces
possess like partial charges, they too experience a repulsive electrostatic force. The
total potential energy of interaction can be determined by the addition of repulsive
and attractive potential energies. Commercially available DMPC and DHPC are only
around 99% pure and rest is impurities which can be charged. Additional hydrolysis
of phospholipids produces either a charged lipid or a partially ionized fatty acid.
The released fatty acid could contribute to an amount of surface charge sufficient to
stabilize, the neutral bicelles in water.
Other types of alignment media like polyacrylamide gels and paramagnetic tags were
also used for alignment of the free NCoA-1(257−370) fragment. The high concentration
of polyacrylamide needed to ensure mechanical stability is a serious limitation of
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neutral polyacrylamide gels, for alignment of proteins. The high concentration of
acrylamide will decrease the pore size of the gel and hence the rotational diffusion
of the protein will be heavily affected even for weak alignment conditions lead-
ing to extensive line broadening[212]. When the free NCoA-1(257−370) fragment and
the NCoA-1(257−370) fragment subjected to reaction with the paramagnetic tag were
analyzed by mass spectroscopy, the expected and observed molecular weights did
not match for both the free NCoA-1(257−370) fragment used as a control and NCoA-
1(257−370) fragment subjected to reaction with the tag. The discrepancy between the
experimental molecular weight and expected weight of the tagged NCoA-1 does not
have an explanation.
4.2.1 Scope for further studies
Residual dipolar couplings obtained in the case of NCoA-1 were not suitable for
structural analysis because of the fact they were too small to be outside the statistical
error range. The reason for this was that the nature of the protein domain did not
permit the right alignment conditions to obtain appropriately large dipolar couplings.
A number of alignment media for proteins have been developed but none of them
have universal application. Disk shaped phospholipid particles or bicelles have narrow
temperature ranges and crystalline conditions are established upon a very delicate
phase equilibrium, which can be disrupted by the soluble macromolecules. Since
the filamentous phages are charged they tend to interact unfavorably with oppositely
charged macromolecules which could destroy the nematic phase or induce excessive
order resulting in unacceptably broad lines. Polyacrylamide gels should be highly
concentrated for mechanical stability but this could result in difficulties in diffusing
the protein samples into the gels. Paramagnetic tags cannot be used where there are
too many cysteins in a polypeptide available for reaction with the tag or where none
are available at all. Hence there is clearly a need to develop newer alignment media
with wider applicability. In the case of NCoA-1 since the RDC based approach did not
lead to any reasonable conclusion, the conventional methods of side chain resonance
assignment along with NOE data could be used to calculate the structure.
It has been shown by Litterst et al., that the amino terminal region of NCoA-1
comprising of amino acids 1 - 381 is required for its interaction with the transactivation
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domain of another STAT protein, the STAT5. This region overlaps with the NCoA-
1 domain used in the present study. Since the interaction between the NCoA-1 and
STAT5 transactivation domain has not yet been structurally characterized, the backbone
resonance assignments for a part of the amino terminal region of NCoA-1 from residues
257-370 could be used to investigate whether the same region of NCoA-1 that is
essential for its interaction with the STAT6 transactivation domain is also involved in
the interaction with STAT5 transactivation domain. It would be interesting to study the
dynamics of such an interaction.
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